IIOT-OXYS, Inc. 10-Q

IIOT-OXYS, INC. 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2026 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________________to___________________________ Commission File Number: 000-50773 IIOT-OXYS, INC. (Exact name of registrant as specified in its charter) Nevada 56-2415252 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 705 Cambridge Street , Cambridge , MA 02141 (Address of principal executive offices) (Zip Code) ( 401 ) 307-3092 (Registrant’s telephone number, including area code) Securities registered pursuant to section 12(b) of the Act: Title of Each Class Trading Symbol(s) Name of each exchange on which registered Not applicable Not applicable Not applicable Securities registered pursuant to Section 12(g) of the Act: Common Stock, Par Value $0.001 Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ Smaller reporting company ☒ Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒ The number of shares outstanding of the registrant’s common stock on July 9, 2026 was 586,385,063 . TABLE OF CONTENTS PART I—FINANCIAL INFORMATION 3 Item 1. Financial Statements 3 Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 30 Item 3. Quantitative and Qualitative Disclosures About Market Risk 36 Item 4. Controls and Procedures 36 PART II—OTHER INFORMATION 36 Item 5. Other Information. 37 Item 6. Exhibits. 37 SIGNATURES 38 Introductory Comment Unless otherwise indicated, any reference to “the Company”, “our company”, “we”, “us”, or “our” refers to IIOT-OXYS, Inc., a Nevada corporation, and as applicable to its wholly owned subsidiaries, OXYS Corporation, a Nevada corporation, and HereLab, Inc., a Delaware corporation. 2 PART I—FINANCIAL INFORMATION Item 1. Financial Statements IIOT-OXYS, Inc. and Subsidiaries Condensed Consolidated Balance Sheets March 31, 2026 December 31, 2025 (Unaudited) ASSETS Current Assets Cash and cash equivalents $ 6,838 $ 26,342 Total Current Assets 6,838 26,342 Total Assets $ 6,838 $ 26,342 LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) Current Liabilities Accounts payable $ 187,552 $ 196,794 Accrued liabilities 1,322,046 1,141,681 Deferred revenue 31,425 31,425 Notes payable - current 13,942 13,942 Derivative liabilities 1,105,758 951,532 Total Current Liabilities 2,660,723 2,335,374 Due to stockholders 1,000 1,000 Total Liabilities 2,661,723 2,336,374 Commitments and Contingencies (Note 3) – Series B Convertible Preferred Stock, 600 shares designated, $ 0.001 Par Value, $ 1,200 stated value; 583 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively. Liquidation preference $ 699,600 at March 31, 2026 and December 31, 2025, respectively 699,600 699,600 Series C Convertible Preferred Stock, 5,000 shares designated, $ 0.001 Par Value, $ 1,200 stated value; 57 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively. Liquidation preference $ 68,400 at March 31, 2026 and December 31, 2025, respectively 68,400 68,400 Series D Convertible Preferred Stock, 500 shares designated, $ 0.001 Par Value, $ 1,200 stated value; 253 shares and 210 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively. Liquidation preference $ 303,600 and $ 252,000 at March 31, 2026 and December 31, 2025, respectively 303,600 252,000 Stockholders' Equity (Deficit) Preferred Stock, $ 0.001 par value, 10,000,000 Shares authorized Series A Preferred Stock, 100 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively – – Series E Preferred Stock, 1,207 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively 1 1 Common Stock $ 0.001 Par Value, 10,000,000,000 shares authorized; 586,385,063 shares and 586,285,063 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively 586,386 586,286 Additional paid in capital 8,730,313 8,733,193 Accumulated deficit ( 13,043,185 ) ( 12,649,512 ) Total Stockholders' Equity (Deficit) ( 3,726,485 ) ( 3,330,032 ) Total Liabilities and Stockholders' Equity (Deficit) $ 6,838 $ 26,342 The accompanying notes are an integral part of these condensed unaudited consolidated financial statements. 3 IIOT-OXYS, Inc. and Subsidiaries Condensed Consolidated Statements of Operations (Unaudited) For The Three Months Ended March 31, 2026 2025 Revenues $ – $ – Cost of Sales – – Gross Profit – – Operating Expenses Amortization of intangible assets – 12,205 Payroll expense – 50,000 Professional fees 56,224 14,585 Other general and administrative 7,365 15,468 Total Operating Expenses 63,589 92,258 Other Income (Expense) Gain (loss) on change in FMV of derivative liability ( 97,220 ) 15,764 Loss on derivatives ( 16,866 ) ( 14,224 ) Interest expense ( 49,084 ) ( 75,375 ) Other income 597 8,882 Total Other Income (Expense) ( 162,573 ) ( 64,953 ) Net Loss Before Income Taxes ( 226,162 ) ( 157,211 ) Provision for Income Tax – – Net Loss ( 226,162 ) ( 157,211 ) Convertible Preferred Stock Dividend ( 167,511 ) ( 23,102 ) Net Loss Attributable to Common Stockholders $ ( 393,673 ) $ ( 180,313 ) Net Profit (Loss) Per Share Attributable to Common Stockholders - Basic and Diluted $ ( 0.00 ) $ ( 0.00 ) Weighted Average Shares Outstanding Attributable to Common Stockholders - Basic and Diluted 586,292,841 556,489,737 The accompanying notes are an integral part of these condensed unaudited consolidated financial statements. 4 IIOT-OXYS, Inc. and Subsidiaries Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) For the Three Months Ended March 31, 2026 Preferred Stock Common Stock Additional Paid-In Accumulated Total Stockholders' Equity Series A Amount Series E Amount Shares Amount Capital Deficit (Deficit) Balance - December 31, 2025 100 $ – 1,207 $ 1 586,285,063 $ 586,286 $ 8,733,193 $ ( 12,649,512 ) $ ( 3,330,032 ) Common stock issued for services – – – – 100,000 100 ( 20 ) – 80 Sales commission paid on capital raise – – – – – – ( 2,860 ) – ( 2,860 ) Convertible preferred stock dividend – – – – – – – ( 167,511 ) ( 167,511 ) Net loss – – – – – – – ( 226,162 ) ( 226,162 ) Balance - March 31, 2026 100 $ – 1,207 $ 1 586,385,063 $ 586,386 $ 8,730,313 $ ( 13,043,185 ) $ ( 3,726,485 ) For the Three Months Ended March 31, 2025 Preferred Stock Common Stock Additional Paid-In Accumulated Total Stockholders' Equity Series A Amount Series E Amount Shares Amount Capital Deficit (Deficit) Balance - December 31, 2024 25,845 $ 26 – $ – 555,015,293 $ 555,016 $ 7,306,031 $ ( 11,208,252 ) $ ( 3,347,179 ) Sales commission paid on capital raise – – – – – – ( 9,200 ) – ( 9,200 ) Common stock issued for services – – – – 300,000 300 60 – 360 Common stock issued to related parties for services – – – – 5,000,000 5,000 1,000 – 6,000 Convertible preferred stock dividend – – – – – – – ( 23,102 ) ( 23,102 ) Net loss – – – – – – – ( 157,211 ) ( 157,211 ) Balance - March 31, 2025 25,845 $ 26 – $ – 560,315,293 $ 560,316 $ 7,297,891 $ ( 11,388,565 ) $ ( 3,530,332 ) The accompanying notes are an integral part of these condensed unaudited consolidated financial statements. 5 IIOT-OXYS, Inc. and Subsidiaries Condensed Consolidated Statements of Cash Flows (Unaudited) For the Three Months Ended March 31, 2026 2025 Cash Flows From Operating Activities Net loss $ ( 226,162 ) $ ( 157,211 ) Adjustments to reconcile net loss to net cash (used in) provided by operating activities Stock compensation expense for services – 1,295 Amortization of intangible assets – 12,205 Common stock issued for services 100 – Amortization of debt discount on Series B and D Preferred Stock 8,600 12,000 Loss (Gain) on change in fair value of derivative liability 97,220 ( 15,764 ) Changes in Operating Assets and Liabilities Decrease in prepaid expenses and other current assets – ( 15,000 ) (Decrease) Increase in accounts payable ( 9,242 ) ( 34,827 ) Increase in accrued liabilities 12,854 38,986 Increase in derivative liability 57,006 69,825 Increase in shares payable to related parties – 360 Increase in salaries payable to related parties – 31,599 Net Cash Used in Operating Activities ( 59,624 ) ( 56,532 ) Cash Flows from Financing Activities Cash received from sale of Series D Preferred Stock 43,000 60,000 Cash paid for offering costs ( 2,880 ) ( 9,200 ) Net Cash Provided By Financing Activities 40,120 50,800 Net Increase in Cash and Cash Equivalents ( 19,504 ) ( 5,732 ) Cash and Cash Equivalents - Beginning of Period 26,342 23,593 Cash and Cash Equivalents - End of Period $ 6,838 $ 17,861 Supplement Disclosures of Cash Flow Information Interest paid $ – $ – Income taxes paid $ – $ – Supplemental Disclosures of Non-Cash Investing and Financing Activities Preferred stock dividend declared but unpaid $ 167,511 $ 23,102 Issuance of common stock for services $ 80 $ 6,360 The accompanying notes are an integral part of these condensed unaudited consolidated financial statements. 6 IIOT-OXYS, Inc. and Subsidiaries Notes to Condensed Consolidated Financial Statements March 31, 2026 and 2025 (Unaudited) NOTE 1 – NATURE OF OPERATIONS, BASIS OF PRESENTATION AND GOING CONCERN Unless otherwise indicated, any reference to “the Company”, “we”, “us”, or “its” refers to IIOT-OXYS, Inc., a Nevada corporation, and as applicable to its wholly owned subsidiaries, OXYS Corporation, a Nevada corporation, and HereLab, Inc., a Delaware corporation. IIOT-OXYS, Inc., incorporated in Nevada on July 6, 2017, (the “ Company ”) was established for the purpose of designing, building, testing, and selling Edge Computing Systems for the Industrial Internet. The Company is currently devoting substantially all its efforts in identifying, developing and marketing engineered products, software and services for applications in the Industrial Internet which involves collecting and processing data collected from a wide variety of industrial systems and machines. On October 30, 2025, the Company had a change of control in management, and the Company and its debtholders mutually agreed to convert their convertible promissory notes due, and compensation due to officers in exchange for issuance of Series E Preferred Stock in full settlement of all balances due (Note 3, Note 6 and Note 7). Basis of Presentation The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“ GAAP ”) and include the accounts of the Company. The financial statements and accompanying notes are the representations of the Company’s management, who is responsible for their integrity and objectivity. In the opinion of the Company’s management, the financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. Going Concern The accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As shown in the accompanying financial statements as of March 31, 2026, the Company has suffered continuing operating losses, has a (a) working capital deficit of $ 2,653,885 , (b) net loss from operations for the three months ended March 31, 2026 of $ 393,673 , (c) cash used in operating activities of $ 59,624 , and (d) accumulated deficit of $ 13,043,185 . These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. If the Company is unable to obtain adequate capital, it could be forced to cease operations. The accompanying condensed financial statements do not include any adjustments to reflect the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. Management believes that the Company will be able to achieve a satisfactory level of liquidity to meet the Company’s obligations for the next twelve months by generating cash through additional borrowings and/or sale of equity securities, as needed. However, there can be no assurance that the Company will be able to generate sufficient liquidity to maintain its operations. The financial statements do not include any adjustments that might result from the outcome of these uncertainties. 7 NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES The following summary of the significant accounting policies of the Company is presented to assist in the understanding of the Company’s financial statements. These accounting policies conform to the generally accepted accounting principles (the “GAAP”) in all material respects and have been consistently applied in preparing the accompanying consolidated financial statements. Interim Financial Statements The accompanying unaudited interim condensed consolidated financial statements and related notes have been prepared in accordance with GAAP for interim financial information, and in accordance with the rules and regulations of the United States Securities and Exchange Commission (the “SEC”) with respect to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The unaudited interim condensed consolidated financial statements furnished reflect all adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary for a fair statement of the results for the interim periods presented. Interim results are not necessarily indicative of the results for the full year. These unaudited interim condensed consolidated financial statements should be read in conjunction with the audited financial statements of the Company for the year ended December 31, 2025, filed with the SEC on May 11, 2026. Principles of Consolidation The consolidated condensed financial statements for March 31, 2026 and 2025, respectively, include the accounts of the Company, and its wholly owned subsidiaries OXYS Corporation and HereLab, Inc. All significant intercompany balances and transactions have been eliminated. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the valuation of accounts payable, accrued liabilities and payable to related parties. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Basic and Diluted Earnings (Loss) Per Common Share The Company computes earnings (loss) per share in accordance with Financial Accounting Standards Board Accounting Standards Codification (“ ASC ”), ASC 260, “ Earnings per Share” . ASC 260 requires presentation of both basic and diluted earnings per share (“ EPS ”) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible note and preferred stock using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. 8 Revenue Recognition The Company recognizes revenue when the products are delivered to the customer or services are performed in accordance with the contractual terms of the contract with its customer. The Company recognizes revenue in accordance with ASC Topic No. 606, Revenue from Contracts with Customers, which was adopted on January 1, 2018. The Company recognizes revenue based on the following criteria of ASC 606: · Identification of a contract or contracts with a customer. · Identification of the performance obligations in the contract. · Determination of contract price. · Allocation of transaction price to the performance obligation. · Recognition of revenue when, or as, performance obligation is satisfied. The Company used a practical expedient available under ASC 606-10-65-1(f)4 that permits it to consider the aggregate effect of all contract modifications that occurred before the beginning of the earliest period presented when identifying satisfied and unsatisfied performance obligations, transaction price, and allocating the transaction price to the satisfied and unsatisfied performance obligations. The Company has elected to treat shipping and handling activities as the cost of sales. Additionally, the Company has elected to record revenue net of sales and other similar taxes. Segment Information The Company’s Chief Executive Officer (“CEO”) is our chief operating decision maker (“CODM”) and evaluates performance and makes operating decisions about allocating resources based on financial data presented on a consolidated basis. The Company is devoting all its efforts to identifying technologies in developing and marketing engineered products, software and services for applications in the Industrial Internet, which involves collecting and processing data collected from a wide variety of industrial systems and machines. The Company’s CODM has determined that it operates as a single reportable segment. Recent Accounting Pronouncements In November 2024, the FASB issued ASU 2024-03 – Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40); Disaggregation of Income Statement Expenses . ASU 2024-03 is effective for public business entities for annual periods beginning after December 15, 2026. The Company is currently evaluating the impact, if any, that the updated standard will have on the consolidated financial statements. 9 NOTE 3 – COMMITMENTS AND CONTINGENCIES 2017 Stock Incentive Plan & 2019 Stock Incentive Plan In prior years, the Company entered into consulting agreements with one director, three executive officers, and one engineer of the Company, which included commitments to issue shares of the Company’s common stock from the Company’s 2017 Stock Incentive Plan (“2017 Plan”) and 2019 Stock Incentive Plan (“2019 Plan”). The authorized shares pursuant to the 2017 Plan were 4,500,000 shares, and per 2019 Plan were 5,000,000 shares. In the event that a consulting agreement is terminated by either party pursuant to the terms of the agreement, all unvested shares which have been earned shall vest on a pro-rata basis as of the effective date of the termination of the agreement and all unearned, unvested shares shall be terminated. The value of the shares was assigned to a fair market value on the effective date of the agreement and the pro-rata number of shares earned was calculated and amortized at the end of each reporting period. The consulting agreements with two consultants have been terminated and shares have been issued in conjunction with the related separation agreements. According to the terms of the agreements, 3,547,788 shares were vested and issued per the Company’s 2017 Plan as of December 31, 2025 and 2024, and 3,530,000 shares were vested and issued per the Company’s 2019 Plan as of December 31, 2025 and 2024, respectively. 2022 Stock Incentive Plan On March 18, 2022, the Company adopted 2022 Stock Incentive Plan (“2022 Plan”) and reserved 20,000,000 shares of common stock for issuance to incentivize its management team. Pursuant to the terms of the 2022 Plan, 14,300,000 shares of common stock were vested and 14,200,000 shares and 3,100,000 were issued as of December 31, 2025 and 2024, respectively. 100,000 shares vested remained to be issued to an advisor pursuant to 2022 Plan as of December 31, 2025, and were issued to the advisor on March 24, 2026. On October 30, 2025, the Company had a change in control of management and all unvested shares pursuant to the 2017 Plan, 2019 Plan, and 2022 Plan were forfeited and cancelled. The Board of Directors subsequently terminated each of the 2017 Plan, the 2019 Plan, and the 2022 Plan effective December 31, 2025. As of December 31, 2025, there were no unvested shares remaining under any of the Plans. Employment Agreement – CEO On October 30, 2025, the Company had a change in control of the management, and the Employment Agreement of Mr. Cliff Emmons, CEO of the Company, was terminated. The Company entered into a Consulting Agreement with Mr. Emmons pursuant to which Mr. Emmons will receive a monthly fee of $ 4,167 payable in Series E Preferred Stock issuable no later than 15 days following the end of the month. The term of the Consulting Agreement was for three months which is automatically renewable upon the consent of the parties for additional one-month terms. The Company recorded $ 12,500 in Consulting fees expense for the three months ended March 31, 2026. Consulting fees and reimbursable expenses payable to Mr. Emmons totaled $ 25,068 and $ 8,402 at March 31, 2026 and December 31, 2025, respectively. NOTE 4 – CONVERTIBLE NOTES PAYABLE The following table summarizes the outstanding balance of convertible note payable, interest and conversion rates as of March 31, 2026 and December 31, 2025, respectively. Schedule of outstanding balance of convertible notes payable March 31, 2026 (Unaudited) December 31, 2025 Convertible note payable (Note “G”) to an investor with interest at 10% per annum, convertible at any time into shares of common stock at $0.0006 per share. Note was issued as payment for future fees to be incurred under the related Equity Financing Agreement. Principal and interest due on maturity on October 31, 2026. The note is secured by substantially all the assets of the Company. $ 13,942 $ 13,942 13,942 13,942 Less current portion ( 13,942 ) ( 13,942 ) Long term portion $ – $ – 10 July 2020 Equity Financing Arrangement (“Note G”) On October 29, 2025, the noteholder of Note G agreed to extend the maturity date of the Secured Convertible Promissory Note from October 29, 2025 to April 29, 2026, and then further extended to October 31, 2026. All other terms and conditions of the Note G remained the same. The Company recorded interest expense on Note G of $ 344 and $ 344 for the three months ended March 31, 2026 and 2025, respectively. Accrued interest payable on Note G was $ 2,861 and $ 2,517 as of March 31, 2026 and December 31, 2025, respectively. The principal balance payable of Note G totaled $ 13,942 as of March 31, 2026 and December 31, 2025, respectively. NOTE 5 – EARNINGS (LOSS) PER SHARE The following table sets forth the computation of basic and diluted net loss per share of common stock for the three months ended March 31, 2026 and 2025, respectively: Schedule of computation of basic and diluted net loss per share of common stock Three Months Ended March 31, 2026 2025 Net loss attributable to common stockholders (basic) $ ( 393,673 ) $ ( 180,313 ) Shares used to compute net loss per common share, basic and diluted 586,292,841 556,489,737 Net loss per share attributable to common stockholders, basic and diluted $ ( 0.00 ) $ ( 0.00 ) Basic net loss per share is calculated by dividing net loss by the weighted average number of common shares outstanding during the period. Diluted net loss per share is computed by dividing net loss by the weighted-average number of common shares and common share equivalents outstanding for the period. Common stock equivalents are only included when their effect is dilutive. The Company’s potentially dilutive securities, which include stock options, convertible debt, convertible preferred stock and common stock warrants have been excluded from the computation of diluted net loss per share as they would be anti-dilutive. For all periods presented, there is no difference in the number of shares used to compute basic and diluted shares outstanding due to the Company’s net loss position. The following outstanding common stock equivalents have been excluded from diluted net loss per common share for the three months ended March 31, 2026 and 2025, respectively, because their inclusion would be anti-dilutive: Schedule of anti-dilutive shares As of March 31, 2026 2025 Potentially issuable shares related to convertible notes payable 18,670,141 777,016,043 Potentially issuable vested shares to directors and officers – 8,200,000 Potentially issuable unvested shares to directors and officers – 6,100,000 Total anti-dilutive common stock equivalents 18,670,141 791,316,043 11 NOTE 6 – RELATED PARTIES The Company executed a Convertible Promissory Note (“Note”) payable to its CEO and director (“Officer”) and indebted in the principal amount of $ 55,000 as of December 31, 2023. On February 5, 2024, the Company and the Officer entered into a Debt Exchange Agreement to convert $ 55,000 principal balance of Note and $ 13,825 of accrued and unpaid interest as of the maturity date of Note on March 1, 2024 . In exchange for the cancellation of all indebtedness of the Company owed the Officer as evidenced by the Note, and for no additional consideration, the Company agreed to issue to Officer 57 shares of the Company’s Series C Convertible Preferred Stock, at the stated value of $1,200 per share (See Note 7). Accrued dividend payable on this Convertible Preferred Stock (including default for non-payment of dividend) totaled $ 30,547 and $ 26,330 as of March 31, 2026 and December 31, 2025, respectively. On October 30, 2025, the Company had a change in control and GHS Investments, LLP became the majority owner of the issued and outstanding shares of common and preferred stock (See Note 5 and Note 8). On October 30, 2025, the Company entered into a Consulting Agreement (the “Consulting Agreement”) with its Officer, pursuant to which the Officer agreed to receive a monthly fee of $ 4,167 payable in Series E Preferred Stock issuable no later than 15 days following the end of the month. The term of the Consulting Agreement is for three months, which is automatically renewable upon the consent of the parties for additional one-month terms. The Company has not issued Series E Preferred Stock for the Officer’s unpaid compensation as of March 31, 2026. The Company has recorded consulting fees expense of $ 12,500 for the three months ended March 31, 2026. Consulting fees and reimbursable expenses payable to the Officer totaled $ 25,068 and $ 8,402 as of March 31, 2026 and December 31, 2025, respectively. The expected number of Series E Preferred Stock to be issued totaled 21 shares and 7 shares as of March 31, 2026 and December 31, 2025, respectively. On October 30, 2025, the Company entered into a Debt Exchange Agreement (the “Emmons DEA”) with Clifford L. Emmons, it’s Chief Executive Officer and Director. Pursuant to the Emmons DEA, Mr. Emmons exchanged $ 387,242 of accrued compensation and unpaid fees owed to him by the Company under various agreements, for 269 shares of the Company’s Series E Convertible Preferred Stock (the “Series E Preferred Stock”). In addition to the issuance of the Company’s Series E Preferred Stock, Mr. Emmons agreed to cancel 7,800 shares of Series A Preferred Stock owned by him. The closing of the Emmons DEA occurred on November 5, 2025. The Company recorded dividend expense of $ 4,217 for the three months ended March 31, 2026, The Company recorded $ 30,547 and $ 26,330 as dividend payable to Mr. Emmons as of March 31, 2026 and December 31, 2025, respectively (Note 7). NOTE 7 – STOCKHOLDERS' EQUITY The Company has an authorized capital of 10,000,000,000 shares, $ 0.001 par value common stock, and 10,000,000 shares of $ 0.001 par value preferred stock at March 31, 2026. The Company has 586,385,063 shares of common stock, 100 shares of Series A Preferred Stock, 583 shares of Series B Preferred Stock, 57 shares of Series C Preferred Stock, 253 shares of Series D Preferred Stock, and 1,207 shares of Series E Preferred Stock issued and outstanding as of March 31, 2026. Common Stock Holders of shares of common stock are entitled to one vote for each share on all matters to be voted on by the stockholders. Holders of common stock do not have cumulative voting rights. Holders of common stock are entitled to share ratably in dividends, if any, as may be declared from time to time by the Board of Directors in its discretion of funds legally available, therefore. In the event of liquidation, dissolution, or winding up of the Company, the holders of common stock are entitled to share pro rata in all assets remaining after payment in full of all liabilities. All of the outstanding shares of common stock are fully paid and non-assessable. Holders of common stock have no preemptive rights to purchase the Company’s common stock. There are no conversion or redemption rights or sinking fund provisions with respect to the common stock. Stock Incentive Plans On December 14, 2017, the Board of Directors of the Company approved the 2017 Stock Incentive Plan (the “ 2017 Plan ”). Awards may be made under the 2017 Plan for up to 4,500,000 shares of common stock of the Company. All the Company’s employees, officers and directors, as well as consultants and advisors to the Company are eligible to be granted awards under the 2017 Plan. No awards can be granted under the 2017 Plan after the expiration of 10 years from the plan approval, but awards previously granted may extend beyond that date. Awards may consist of both incentive and non-statutory options, restricted stock units, stock appreciation rights, and restricted stock awards. On October 30, 2025, the Company cancelled 952,212 unissued shares pursuant to the 2017 Plan. As of March 31, 2026 and December 31, 2025, 0 shares remain unissued or unvested pursuant to the 2017 Plan. 12 On March 11, 2019, the Board of Directors of the Company approved the 2019 Stock Incentive Plan (the “ 2019 Plan ”). Awards may be made under the 2019 Plan for up to 5,000,000 shares of common stock of the Company. All of the Company’s employees, officers and directors, as well as consultants and advisors to the Company are eligible to be granted awards under the 2019 Plan. No awards can be granted under the 2019 Plan after the expiration of 10 years from the plan approval but awards previously granted may extend beyond that date. Awards may consist of both incentive and non-statutory options, restricted stock units, stock appreciation rights, and restricted stock awards. On October 30, 2025, the Company cancelled 1,270,000 unissued shares pursuant to the 2019 Plan. As of March 31, 2026 and December 31, 2025, 0 shares remain unissued or unvested pursuant to the 2019 Plan. On March 18, 2022, the Board of Directors adopted the 2022 Stock Incentive Plan (the “ 2022 Plan ”), under which 20,000,000 shares of common stock were authorized for issuance. The Company has awarded 14,300,000 shares under the 2022 Plan, of which 14,200,000 were issued as of December 31, 2025 and 100,000 shares were issued on March 24, 2026. In connection with the change of control on October 30, 2025, 6,000,000 unvested shares were cancelled. The 2022 Plan was terminated effective December 31, 2025 pursuant to a resolution of the Board of Directors. Shares earned and issued related to the consulting agreements are issued under the 2017 Stock Incentive Plan and the 2019 Stock Incentive Plan (see Note 3). A summary of the status of the Company’s non-vested shares at March 31, 2026 and 2025 and changes during the three months ended, is presented below: Schedule of non-vested shares 2022 Stock Incentive Plan Shares of Common Stock Weighted Average Exercise Price Authorized shares per the 2022 Plan – 20,000,000 shares Balance - December 31, 2024 11,200,000 $ – Awarded – 0.006146 Issued ( 5,100,000 ) – Forfeited – – Balance – March 31, 2025 – (Unvested) 6,100,000 $ 0.006146 Balance - December 31, 2025 6,100,000 $ 0.006146 Awarded – – Issued ( 100,000 ) 0.006146 Forfeited ( 6,000,000 ) – Balance – March 31, 2026 – (Unvested) – $ – Preferred Stock Series A Supervoting Convertible Preferred Stock The Board of Directors of the Company authorized the issuance of 25,845 shares of preferred stock, $ 0.001 par value per share, designated as Series A Supervoting Preferred Stock. On October 30, 2025, the Company entered into a Stock Purchase Agreement with GHS Investments, LLC, a Nevada limited liability company (“GHS”), pursuant to which, upon occurrence of certain conditions, including defaults by the Company under its agreements with GHS and subsequent waivers and extensions thereof by GHS, the Company would issue to GHS 100 shares of the Company’s Series A Supervoting Preferred Stock. On November 5, 2025, the closing of the Stock Purchase Agreement occurred, and GHS was issued 100 shares of Series A Supervoting Preferred Stock. 13 Dividends: Initially, there will be no dividends due or payable on Series A Supervoting Preferred Stock. Any future terms with respect to dividends shall be determined by the Board consistent with the Company’s Articles of Incorporation. Liquidation and Redemption Rights: Upon the occurrence of a Liquidation Event (as defined below), the holders of Series A Supervoting Preferred Stock are entitled to receive net assets on a pro-rata basis. Each holder of Series A Supervoting Preferred Stock is entitled to receive ratably any dividends declared by the Board, if any, out of funds legally available for the payment of dividends. Liquidation Event means (i) the liquidation, dissolution or winding-up, whether voluntary or involuntary, of the Company, (ii) the purchase or redemption by the Company of the shares of any class of stock or the merger or consolidation of the Company with or into any other corporation or corporations, or (iii) the sale, license or lease of all or substantially all, or any material part of, the Company’s assets. Conversion: Each holder of Series A Supervoting Preferred Stock may voluntarily convert its shares into shares of common stock of the Company at a rate of 1:100 (as may be adjusted for any combinations or splits with respect to such shares). Rank: All shares of the Series A Supervoting Preferred Stock shall rank senior to the Company’s (A) common stock, par value $0.001 per share, and any other class or series of capital stock of the Company hereafter created. Voting Rights: A. If at least one share of Series A Super Voting Preferred Stock is issued and outstanding, then the total aggregate issued shares of Series A Super Voting Preferred Stock at any given time, regardless of their number, shall have voting rights equal to 20 times the sum of: i) the total number of shares of Common stock which are issued and outstanding at the time of voting, plus ii) the total number of shares of all Series of Preferred stocks which are issued and outstanding at the time of voting. B. Each individual share of Series A Super Voting Preferred Stock shall have the voting rights equal to: [twenty times the sum of: {all shares of Common stock issued and outstanding at the time of voting + all shares of Series A and any newly designated Preferred stock issued and outstanding at the time of voting}] Divided by: [the number of shares of Series A Super Voting Preferred Stock issued and outstanding at the time of voting] With respect to all matters upon which stockholders are entitled to vote or to which stockholders are entitled to give consent, the holders of the outstanding shares of Series A Super Voting Preferred Stock shall vote together with the holders of Common Stock without regard to class, except as to those matters on which separate class voting is required by applicable law or the Articles of Incorporation or Bylaws. The Company had 100 shares of Series A Preferred Stock issued and outstanding at March 31, 2026 and December 31, 2025, respectively. Series B Convertible Preferred Stock Equity Financing On November 16, 2020, the Board of Directors of the Company had authorized issuance of up to 600 shares of preferred stock, $ 0.001 par value per share, designated as Series B Convertible Preferred Stock. Each share of Preferred Stock shall have a par value of $0.001 per share and a stated value of $1,200, subject to the increase set forth in the Certificate of Designation. 14 Dividends: Each share of Series B Convertible Preferred Stock shall be entitled to receive, and the Company shall pay, cumulative dividends of 12% per annum, payable quarterly, beginning on the Original Issuance Date and ending on the date that such share of Series B Convertible Preferred Share has been converted or redeemed (the “Dividend End Date”). Dividends may be paid in cash or in shares of Series B Convertible Preferred Stock. From and after the initial Closing Date, in addition to the payment of dividends pursuant to Section 2(a), each Holder shall be entitled to receive, and the Company shall pay, dividends on shares of Series B Convertible Preferred Stock equal to (on an as-if-converted-to-Common-Stock basis) and in the same form as dividends actually paid on shares of the common stock when, as and if such dividends are paid on shares of the common stock. The Company shall pay no dividends on shares of the common stock unless it simultaneously complies with the previous sentence. Voting Rights : The Series B Convertible Preferred Stock will vote together with the common stock on an as converted basis subject to the Beneficial Ownership Limitations (not in excess of 4.99% conversion limitation). However, as long as any shares of Series B Convertible Preferred Stock are outstanding, the Company shall not, without the affirmative vote of the Holders of a majority of the then outstanding shares of the Series B Convertible Preferred Stock directly and/or indirectly (a) alter or change adversely the powers, preferences or rights given to the Series b Convertible Preferred Stock or alter or amend this Certificate of Designation, (b) authorize or create any class of stock ranking as to redemption or distribution of assets upon a Liquidation (as defined in Section 5) senior to, or otherwise Pari passu with, the Series B Convertible Preferred Stock or, authorize or create any class of stock ranking as to dividends senior to, or otherwise Pari passu with, the Series b Convertible Preferred Stock, (c) amend its Articles of Incorporation or other charter documents in any manner that adversely affects any rights of the Holders, (d) increase the number of authorized shares of Series B Convertible Preferred Stock, or (e) enter into any agreement with respect to any of the foregoing. Liquidation : Upon any liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary (a “Liquidation”), the Holders shall be entitled to receive out of the assets, whether capital or surplus, of the Company an amount equal to the Stated Value, plus any accrued and unpaid dividends thereon and any other fees or liquidated damages then due and owing thereon under this Certificate of Designation, for each share of Series B Convertible Preferred Stock before any distribution or payment shall be made to the holders of any Junior Securities, and if the assets of the Company shall be insufficient to pay in full such amounts, then the entire assets to be distributed to the Holders shall be ratably distributed among the Holders in accordance with the respective amounts that would be payable on such shares if all amounts payable thereon were paid in full. Conversion : Each share of Series B Convertible Preferred Stock shall be convertible, at any time and from time to time from and after the Original Issue Date at the option of the Holder thereof, into that number of shares of common stock (subject to the limitations) determined by dividing the Stated Value of such share of Series B Convertible Preferred Stock by the Conversion Price. The Conversion Price for the Series B Convertible Preferred Stock shall be the amount equal to the lowest traded price for the Company’s common stock for the fifteen (15) Trading Days immediately preceding the date of such conversion. All such foregoing determinations will be appropriately adjusted for any stock dividend, stock split, stock combination, reclassification or similar transaction that proportionately decreases or increases the common stock during such a measuring period. Following an event of default, the Conversion price shall equal the lower of : (a) the then applicable Conversion Price; or (b) a price per share equaling 80% of the lowest traded price for the Company’s common stock during the ten (10) trading days preceding the relevant Conversion. Redemption: The Series B Convertible Preferred Stock may be redeemed by payment of the stated value thereof, with the following premiums based on the time of the redemption. · 115% of the stated value if the redemption takes place within 90 days of issuance · 120% of the stated value if the redemption takes place after 90 days and within 120 days of issuance · 125% of the stated value if the redemption takes place after 120 days and within 180 days of issuance; and · each share of Preferred Stock is redeemed one year from the day of issuance 15 November 19, 2020 On November 19, 2020, pursuant to the terms of a Securities Purchase Agreement dated November 16, 2020 (the “SPA”), the Company entered into a new preferred equity financing agreement with GHS Investments, LLC (“GHS”) in the amount of up to $600,000. The SPA provides for GHS’s purchase, from time to time, of up to 600 shares of the newly designated Series B Convertible Preferred Stock. The initial closing under the SPA consisted of 45 shares of Series B Convertible Preferred Stock, stated value $1,200 per share, issued to GHS for an initial purchase price of $45,000, or $1,000 per share. At the Company’s option, and subject to the terms of the SPA and the Certificate of Designation for the Series B Convertible Preferred Stock (the “COD”), additional closings in the amount of 40 shares of Series B Convertible Preferred Stock for a total purchase price of $40,000 may take place at a rate of up to once every 30 days. In connection with the initial closing in the amount of 45 shares of Series B Convertible Preferred Stock, the Company issued an additional 25 shares of Series B Convertible Preferred Stock to GHS as a commitment fee. No additional closing may take place after the two-year anniversary of the SPA, or once the entire $600,000 amount has been funded. If the average daily dollar trading volume for the Company’s common stock for the 30 trading days preceding a particular additional closing is at least $50,000 per day, the Company may, at its option, increase the amount of that additional closing to 75 shares of Series B Convertible Preferred Stock ($75,000). The Series B Convertible Preferred Stock is classified as temporary equity, as it is convertible upon issuance at an amount equal to the lowest traded price for the Company’s common stock for the fifteen trading days immediately preceding the date of conversion. Based on the requirements of ASC 815, Derivatives and Hedging , the conversion feature represents an embedded derivative that is required to be bifurcated and accounted for as a separate derivative liability. The derivative liability is originally recorded at its estimated fair value and is required to be revalued at each conversion event and reporting period. Changes in the derivative liability fair value are reported in operating results for each reporting period. On November 19, 2020, GHS purchased a total of 70 shares of Series B Convertible Preferred Stock for gross proceeds of $ 45,000 . The Company paid $ 900 in selling commissions to complete this financing. On November 19, 2020 (the date of receipt of cash proceeds of $45,000 issuance), the Company valued the fair value of the derivative and recorded an initial derivative liability of $ 103,267 , $ 58,267 as day one loss on the derivative, $ 39,000 as interest expense, and $ 39,000 as Series B Convertible Preferred Stock mezzanine liability, and $ 45,000 as a loss recorded on issuance to interest expense. The expected term of the derivative in calculating the fair value of derivative liability is eighteen months. The Company recalculated the value of the derivative liability associated with this convertible preferred stock and recorded a loss in connection with the change in fair market value of the derivative liability of $ 6,630 for the three months ended March 31, 2026, and a gain of $ 2,751 for the three months ended March 31, 2025, respectively. The Company recorded preferred dividend expense of $ 18,334 and $ 2,485 for the three months ended March 31, 2026 and 2025, respectively. The Company recorded $ 197,874 and $ 179,540 as preferred stock dividend payable as of March 31, 2026 and December 31, 2025, respectively. The preferred stock dividend payable at March 31, 2026 included $139,406 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. GHS waived the cumulative penalty of $139,406 for non-payment of dividend as of March 31, 2026. Derivative liability payable for this transaction totaled $ 84,947 and $ 78,317 at March 31, 2026 and December 31, 2025, respectively. Series B Convertible Preferred Stock mezzanine liability was $ 84,000 at March 31, 2026 and December 31, 2025, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise prices ranging from $0.0004 to $0.0141, the closing stock price of the Company's common stock on the date of valuation ranging from $0.0006 to $0.0184, an expected dividend yield of 0%, expected volatility ranging from 160.41% to 440.99%, risk-free interest rates ranging from 0.07% to 5.46%, and an expected term ranging from 0.13 years to 1.50 years. 16 December 16, 2020 On December 16, 2020, pursuant to the terms of the SPA, GHS purchased an additional 85 shares of Series B Convertible Preferred Stock for gross proceeds of $ 85,000 . The Company paid $ 1,700 in selling commissions to complete this financing. On December 16, 2020 (the date of receipt of cash proceeds of $85,000 issuance), the Company valued the fair value of the derivative and recorded an initial derivative liability of $ 106,241 , $ 21,241 as day one loss on the derivative, $ 17,000 as interest expense, and $ 17,000 as Series B Convertible Preferred Stock mezzanine liability, and $ 85,000 as a loss recorded on issuance to interest expense. The expected term of the derivative in calculating the fair value of derivative liability is eighteen months. The Company recalculated the value of the derivative liability associated with this convertible preferred stock and recorded a loss of $ 8,050 in connection with the change in fair market value of the derivative liability for the three months ended March 31, 2026, and recorded a gain of $ 3,341 for the three months ended March 31, 2025, respectively. The Company recorded preferred dividend expense of $ 21,814 and $ 3,018 for the three months ended March 31, 2026 and 2025, respectively. The Company recorded $ 237,789 and $ 215,975 as preferred stock dividend payable as of March 31, 2026 and December 31, 2025, respectively. The preferred stock dividend payable at March 31, 2026 included $170,942 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. GHS waived the cumulative penalty of $170,902 for non-payment of dividend as of March 31, 2026. Derivative liability payable for this transaction totaled $ 103,150 and $ 95,099 at March 31, 2026 and December 31, 2025, respectively. Series B Convertible Preferred Stock mezzanine liability was $ 102,000 at March 31, 2026 and December 31, 2025, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise prices ranging from $0.0004 to $0.0141, the closing stock price of the Company's common stock on the date of valuation ranging from $0.0006 to $0.0184, an expected dividend yield of 0%, expected volatility ranging from 160.41% to 437.59%, risk-free interest rates ranging from 0.07% to 5.46%, and an expected term ranging from 0.21 years to 1.50 years. December 20, 2021 On December 20, 2021, pursuant to the terms of the SPA, GHS purchased an additional 51 shares of Series B Convertible Preferred Stock for gross proceeds of $ 51,000 . The Company paid $ 1,000 in selling commissions to complete this financing. For the year ended December 31, 2021, the Company inadvertently reported this sale of 51 shares as Series A Preferred stock (See Series A Supervoting Preferred Stock). The accompanying financial statements reflect the correct purchase of Series B Convertible Preferred Stock rather than Series A Convertible Preferred Stock. The overall effect of this correction was not significant to the December 31, 2021 financial statements. The Company recalculated the value of the derivative liability associated with this convertible preferred stock and recorded a loss of $ 4,830 in connection with the change in fair market value of the derivative liability for the three months ended March 31, 2026, and recorded a gain of $ 2,005 for the three months ended March 31, 2025, respectively. The Company recorded preferred dividend expense of $ 25,684 and $ 1,811 for the three months ended March 31, 2026 and 2025, respectively. The Company recorded $ 114,954 and $ 89,270 as preferred stock dividend payable as of March 31, 2026 and December 31, 2025, respectively. The preferred stock dividend payable at March 31, 2026 included $85,337 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. GHS waived the cumulative penalty of $85,604 for non-payment of dividend as of March 31, 2026. Derivative liability payable for this transaction totaled $ 61,890 and $ 57,060 at March 31, 2026 and December 31, 2025, respectively. Series B Convertible Preferred Stock mezzanine liability was $ 61,200 at March 31, 2026 and December 31, 2025, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise prices ranging from $0.0004 to $0.0050 the closing stock price of the Company's common stock on the date of valuation ranging from $0.0006 to $0.0070, an expected dividend yield of 0%, expected volatility ranging from 173.26% to 221.64%, risk-free interest rates ranging from 0.91% to 5.46%, and an expected term of 1.50 years. 17 February 7, 2022 On February 7, 2022, pursuant to the terms of the SPA, GHS purchased an additional 51 shares of Series B Convertible Preferred Stock for gross proceeds of $ 51,000 . The Company paid $ 1,000 in selling commissions to complete this financing. On February 7, 2022 (the date of receipt of cash proceeds of $51,000 issuance), the Company valued the fair value of the derivative and recorded an initial derivative liability of $ 65,025 , $ 14,025 as day one loss on the derivative, $ 10,200 as interest expense, and $10,200 as Series B Convertible Preferred Stock mezzanine liability, and $ 51,000 as a loss recorded on issuance to interest expense. The expected term of the derivative in calculating the fair value of derivative liability is eighteen months. The Company recalculated the value of the derivative liability associated with the convertible note and recorded a loss of $ 4,830 in connection with the change in fair market value of the derivative liability for the three months ended March 31, 2026, and recorded a gain of $ 2,005 for the three months ended March 31, 2025, respectively. In addition, the Company recorded $ 10,560 and $ 1,811 as preferred stock dividend expense for the three months ended March 31, 2026 and 2025, respectively. Preferred stock dividend payable to GHS on this derivative totaled $ 93,607 and $ 83,047 as of March 31, 2026 and December 31, 2025, respectively. The preferred stock dividend payable at March 31, 2026 included $64,975 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. GHS waived the cumulative penalty of $82,787 for non-payment of dividend as of March 31, 2026. The Company did not record the waived penalty in its financial statements as of March 31, 2026 and 2025, respectively. Derivative liability payable for this transaction totaled $ 61,890 and $ 57,060 as of March 31, 2026 and December 31, 2025, and Series B Convertible Preferred Stock mezzanine liability was $ 61,200 as of March 31, 2026 and December 31, 2025, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise prices ranging from $0.0004 to $0.0096, the closing stock price of the Company's common stock on the date of valuation ranging from $0.0006 to $0.0172, an expected dividend yield of 0%, expected volatility ranging from 160.35% to 201.38%, risk-free interest rates ranging from 1.09% to 5.46%, and an expected term of 1.35 to 1.5 years. March 24, 2022 On March 24, 2022, pursuant to the terms of the SPA, GHS purchased an additional 136 shares of Series B Convertible Preferred Stock for gross proceeds of $ 136,000 . The Company paid $ 2,720 in selling commissions to complete this financing. On March 24, 2022 (the date of receipt of cash proceeds of $136,000 issuance), the Company valued the fair value of the derivative and recorded an initial derivative liability of $ 328,422 , $ 192,422 as day one loss on the derivative, $ 27,200 as interest expense, and $ 27,200 as Series B Convertible Preferred Stock mezzanine liability, and $ 136,000 as a loss recorded on issuance to interest expense. The expected term of the derivative in calculating the fair value of derivative liability is eighteen months. The Company recalculated the value of the derivative liability associated with the convertible note and recorded a loss of $ 12,880 in connection with the change in fair market value of the derivative liability for the three months ended March 31, 2026, and recorded a gain of $ 5,345 for the three months ended March 31, 2025, respectively. In addition, the Company recorded $ 10,158 and $ 4,829 as preferred stock dividend expense for the three months ended March 31, 2026 and 2025, respectively. Preferred stock dividend payable to GHS on this derivative totaled $ 215,658 and $ 205,500 as of March 31, 2026 and December 31, 2025, respectively. The preferred stock dividend payable at March 31, 2026 included $141,721 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. GHS waived the cumulative penalty of $213,765 for non-payment of dividend as of March 31, 2026. Derivative liability payable for this transaction totaled $ 165,040 and $ 152,159 as of March 31, 2026 and December 31, 2025, and Series B Convertible Preferred Stock mezzanine liability was $ 163,200 as of March 31, 2026 and December 31, 2025, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise prices ranging from $0.0004 to $0.0096, the closing stock price of the Company's common stock on the date of valuation ranging from $0.0006 to $0.0018, an expected dividend yield of 0%, expected volatility ranging from 160.35% to 202.70%, risk-free interest rates ranging from 1.55% to 5.46%, and an expected term of 1.48 to 1.5 years. 18 November 17, 2022 On November 17, 2022, pursuant to the terms of the SPA, GHS purchased an additional 61 shares of Series B Convertible Preferred Stock for gross proceeds of $ 61,000 . The Company paid $ 1,220 in selling commissions to complete this financing. On November 17, 2022 (the date of receipt of cash proceeds of $61,000 issuance), the Company valued the fair value of the derivative and recorded an initial derivative liability of $ 54,072 , $ 6,928 as day one gain on the derivative, $ 12,200 as interest expense, $ 12,200 as Series B Convertible Preferred Stock mezzanine liability, and $ 61,000 as a loss recorded on issuance to interest expense. The expected term of the derivative in calculating the fair value of derivative liability is eighteen months. The Company recalculated the value of the derivative liability associated with the convertible note and recorded a loss of $ 5,777 in connection with the change in fair market value of the derivative liability for the three months ended March 31, 2026, and recorded a gain of $ 2,398 for the three months ended March 31, 2025, respectively. In addition, the Company recorded $ 10,267 and $ 2,166 as preferred stock dividend expense for the three months ended March 31, 2026 and 2025, respectively. Preferred stock dividend payable to GHS on this derivative totaled $ 85,266 and $ 74,999 as of March 31, 2026 and December 31, 2025, respectively. The preferred stock dividend payable at March 31, 2026 included $57,831 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. GHS waived the cumulative penalty of $85,326 for non-payment of dividend as of March 31, 2026. Derivative liability payable for this transaction totaled $ 74,025 and $ 68,248 as of March 31, 2026 and December 31, 2025, and Series B Convertible Preferred Stock mezzanine liability was $ 73,200 as of March 31, 2026 and December 31, 2025, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise prices ranging from $0.0004 to $0.0020, the closing stock price of the Company's common stock on the date of valuation ranging from $0.0006 to $0.0022, an expected dividend yield of 0%, expected volatility ranging from 173.26% to 201.59%, risk-free interest rates ranging from 3.68% to 5.46%, and an expected term of 1.5 years. August 24, 2023 On August 24, 2023, pursuant to the terms of the SPA, GHS purchased 62 shares of Series B Convertible Preferred Stock for gross proceeds of $ 62,000 . The Company paid $ 1,240 in selling commissions to complete this financing. On August 24, 2023 (the date of receipt of cash proceeds of $62,000 issuance), the Company valued the fair value of the derivative and recorded an initial derivative liability of $ 61,679 , $ 321 as day one gain on the derivative, $ 12,400 as interest expense, and $ 12,400 as Series B Convertible Preferred Stock mezzanine liability, and $ 62,000 as a loss recorded on issuance to interest expense. The expected term of the derivative in calculating the fair value of derivative liability is eighteen months. The Company recalculated the value of the derivative liability associated with the convertible note and recorded a loss of $ 5,872 in connection with the change in fair market value of the derivative liability for the three months ended March 31, 2026, and recorded a gain of $ 2,440 for the three months ended March 31, 2025, respectively. In addition, the Company recorded $ 9,535 and $ 2,201 as preferred stock dividend expense for the three months ended March 31, 2026 and 2025, respectively. Preferred stock dividend payable to GHS on this derivative totaled $ 72,016 and $ 62,481 as of March 31, 2026 and December 31, 2025, respectively. The preferred stock dividend payable at March 31, 2026 included $50,980 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. GHS waived the cumulative penalty of $75,541 for non-payment of dividend as of March 31, 2026. Derivative liability payable for this transaction totaled $ 75,239 and $ 69,367 as of March 31, 2026 and December 31, 2025, and Series B Convertible Preferred Stock mezzanine liability was $74,400 as of March 31, 2026 and December 31, 2025, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise prices ranging from $0.0004 to $0.0014, the closing stock price of the Company’s common stock on the date of valuation ranging from $0.0006 to $0.0015, an expected dividend yield of 0%, expected volatility ranging from 189.98% to 202.70%, risk-free interest rates ranging from 3.68% to 5.46%, and an expected term of 1.5 years. 19 April 16, 2024 On April 16, 2024, pursuant to the terms of the SPA, GHS purchased 20 shares of Series B Convertible Preferred Stock for gross proceeds of $ 17,600 . The Company paid $ 2,400 in selling commissions to complete this financing. On April 16, 2024 (the date of receipt of cash proceeds of $17,600 issuance), the Company valued the fair value of the derivative and recorded an initial derivative liability of $ 20,324 , $ 321 as day one loss on the derivative, $ 4,000 as interest expense, and $ 24,000 as Series B Convertible Preferred Stock mezzanine liability, and $ 20,000 as a loss recorded on issuance to interest expense. The expected term of the derivative in calculating the fair value of derivative liability is one year. The Company recalculated the value of the derivative liability associated with the convertible note and recorded a loss of $ 1,706 in connection with the change in fair market value of the derivative liability for the three months ended March 31, 2026, and recorded a gain of $ 678 for the three months ended March 31, 2025, respectively. In addition, the Company recorded $ 1,957 and $ 710 as preferred stock dividend expense for the three months ended March 31, 2026 and 2025, respectively. Preferred stock dividend payable to GHS on this derivative totaled $ 11,767 and $ 9,810 as of March 31, 2026 and December 31, 2025, respectively. The preferred stock dividend payable at March 31, 2026 included $6,843 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. GHS waived the cumulative penalty of $9,915 for non-payment of dividend as of March 31, 2026. Derivative liability payable for this transaction totaled $ 21,575 and $ 19,870 as of March 31, 2026 and December 31, 2025, and Series B Convertible Preferred Stock mezzanine liability was $ 24,000 as of March 31, 2026 and December 31, 2025, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise prices ranging from $0.0004 to $0.0009, the closing stock price of the Company’s common stock on the date of valuation ranging from $0.0006 to $0.0014, an expected dividend yield of 0%, expected volatility ranging from 186.23% to 205.33%, risk-free interest rates ranging from 3.68% to 5.18%, and an expected term of 1 year. October 3, 2024 On October 3, 2024, pursuant to the terms of the SPA, GHS purchased 43 shares of Series B Convertible Preferred Stock and committed an additional 4 shares for services/fees for gross consideration of $ 43,000 . The Company paid $ 7,860 in selling commissions and legal fees to complete this financing. On October 3, 2024 (the date of receipt of cash proceeds of $39,140), the Company valued the fair value of the derivative and recorded an initial derivative liability of $ 47,000 , $ 16,189 as day one loss on the derivative, $ 9,400 as interest expense, and $ 56,400 as Series B Convertible Preferred Stock mezzanine liability, and $ 39,140 as a loss recorded on issuance to interest expense. The expected term of the derivative in calculating the fair value of derivative liability is one year. The Company recalculated the value of the derivative liability associated with the convertible note and recorded a loss of $ 4,008 and $ 2,865 in connection with the change in fair market value of the derivative liability for the three months ended March 31, 2026 and 2025, respectively. In addition, the Company recorded $4,252 and $ 1,809 as preferred stock dividend expense for the three months ended March 31, 2026 and 2025, respectively. Preferred stock dividend payable to GHS on this derivative totaled $ 21,301 and $ 17,049 as of March 31, 2026 and December 31, 2025, respectively. The preferred stock dividend payable at March 31, 2026 included $12,743 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. GHS waived the cumulative penalty of $21,531 for non-payment of dividend as of March 31, 2026. Derivative liability payable for this transaction totaled $ 50,701 and $ 46,694 as of March 31, 2026 and December 31, 2025, and Series B Convertible Preferred Stock mezzanine liability was $ 56,400 as of March 31, 2026 and December 31, 2025, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise prices ranging from $0.0004 to $0.0009, the closing stock price of the Company’s common stock on the date of valuation ranging from $0.0006 to $0.0012, an expected dividend yield of 0%, expected volatility ranging from 173.26% to 201.59%, risk-free interest rates ranging from 3.68% to 4.16%, and an expected term of 1 year. 20 Series C Convertible Preferred Stock On January 8, 2024, the Board of Directors of the Company had authorized issuance of up to 5,000 shares of preferred stock, $0.001 per share, designated as Series C Convertible Preferred Stock. Each share of Preferred Stock shall have a par value of $0.001 per share and a stated value of $1,200, subject to the increase set forth in the Certificate of Designation. Dividends: Each share of Series C Convertible Preferred Stock shall be entitled to receive, and the Company shall pay, cumulative dividends of 12% per annum, payable quarterly, beginning on the Original Issuance Date and ending on the date that such share of Series C Convertible Preferred Share has been converted or redeemed (the “Dividend End Date”). Dividends may be paid in cash or in shares of Series C Convertible Preferred Stock. From and after the issuance date, in addition to the payment of dividends pursuant to Section 3 (a), each Holder shall be entitled to receive, and the Company shall pay, dividends on shares of Series C Convertible Preferred Stock equal to (on an as-if-converted-to-Common-Stock basis) and in the same form as dividends actually paid on shares of the common stock when, as and if such dividends are paid on shares of the common stock. The Company shall pay no dividends on shares of the common stock unless it simultaneously complies with the previous sentence. Voting Rights : The Holder shall be entitled to vote on an as-converted basis (subject to the Beneficial Ownership Limitation), together with the holders of Common Stock, with respect to any question upon which the holders of Common Stock have the right to vote, except as may be otherwise provided by applicable law. Except as otherwise expressly provided herein or as required by law, the Holders of Series C Preferred Stock and the holders of Common Stock shall vote together and not as separate classes. Liquidation : Upon any liquidation, dissolution or winding up of the Company, whether voluntary or involuntary (a “Liquidation”), the Holders shall be paid, in preference and prior to any payment made to the holders of the Junior Securities and any other stock ranking in liquidation junior to the Series C Preferred Stock, an amount per share equal to the Stated Value (such amount is referred to herein as the “Liquidation Preference”). If upon a Liquidation Event, the assets to be distributed among the Holders shall be insufficient to permit payment in full to the Holders of the Liquidation Preference, then the entire assets of the Company shall be distributed ratably among such holders in proportion to the full respective Liquidation Preference to which they are entitled. Conversion : The Holder shall have the right, at any time to convert such shares into Common Stock into that number of shares of common stock (subject to the Beneficial Ownership Limitation (as defined below)) determined by dividing the Stated Value of such share of Series C Preferred Stock by the Optional Conversion Rate (as defined below) (each, and “Optional Conversion”) at a conversion rate of the volume-weighted average price (“VWAP”) for the Company’s common stock for the ten (10) Trading Days immediately preceding the date of such conversion (the “Optional Conversion Rate”). “Trading Days” shall mean a day on which the means the principal markets or exchange on which the common stock is listed or quoted for trading on the date in question is open for business. “Beneficial Ownership Limitation” shall mean 4.99% of the number of shares of the common stock outstanding immediately after giving effect to the issuance of shares of common stock issuable upon conversion of Series C Preferred Stock held by the applicable Holder. No fractional shares of Common Stock shall be issued upon conversion of shares of Series C Preferred Stock. If more than one share of Series C Preferred Stock shall be surrendered, or deemed surrendered, pursuant to subsection (c) above, for conversion at any one time by the same Holder, the number of full shares of Common Stock issuable upon conversion thereof shall be computed on the basis of the aggregate number of shares of such Series C Preferred Stock so surrendered. Any fractional share which would otherwise be issuable upon conversion of any shares of Series C Preferred Stock (after aggregating all shares of Series C Preferred Stock held by each holder) shall be rounded to the nearest whole number (with one-half being rounded upward). The Company shall reserve, free from preemptive rights, out of its authorized but unissued shares of Common Stock solely for the purpose of effecting the conversion of the shares of Series C Preferred Stock sufficient shares to provide for the conversion of all outstanding shares of Series C Preferred Stock. All shares of Common Stock which may be issued in connection with the conversion provisions set forth herein will, upon issuance by the Company, be validly issued, fully paid and non-assessable, with no personal liability attaching to the ownership thereof, and free from all taxes, liens or charges with respect thereto. 21 All shares of Series C Preferred Stock which have been converted shall no longer be deemed to be outstanding and all rights with respect to such shares including the rights to receive dividends and to vote, shall immediately cease and terminate on the Optional Conversion Date, except only the right of the Holder thereof to receive shares of Common Stock in exchange thereof. The Series C Convertible Preferred Stock is classified as temporary equity, as it is convertible upon issuance at an amount equal to the lowest traded price for the Company’s common stock for the fifteen trading days immediately preceding the date of conversion. Based on the requirements of ASC 815, Derivatives and Hedging , the conversion feature represents an embedded derivative that is required to be bifurcated and accounted for as a separate derivative liability. The derivative liability is originally recorded at its estimated fair value and is required to be revalued at each conversion event and reporting period. Changes in the derivative liability fair value are reported in operating results each reporting period. March 1, 2024 On March 1, 2024, a convertible promissory noteholder and the Company mutually agreed to convert the principal balance of $ 55,000 and accrued interest of $ 13,825 into a total of 57 shares of Series C Convertible Preferred Stock. The Company valued the fair value of the derivative and recorded an initial derivative liability of $ 40,668 , $ 425 as contra interest expense, $28,157 as day one gain on the derivative, $ 68,825 as a loss recorded on issuance to interest expense, and $ 68,825 as Series C Convertible Preferred Stock mezzanine liability. The expected term of the derivative in calculating the fair value of derivative liability is one year. The Company recalculated the value of the derivative liability associated with the convertible note and recorded a loss of $ 11,718 and $ 2,565 in connection with the change in fair market value of the derivative liability for the three months ended March 31, 2026 and 2025, respectively. In addition, the Company recorded $ 4,217 and $ 2,024 as preferred stock dividend expense for the three months ended March 31, 2026 and 2025, respectively. Preferred stock dividend payable to GHS on this derivative totaled $ 30,547 and $ 26,330 as of March 31, 2026 and December 31, 2025, respectively. The preferred stock dividend payable at March 31, 2026 included $15,480 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. GHS waived the cumulative penalty of $21,531 for non-payment of dividend as of March 31, 2026. Derivative liability payable for this transaction totaled $ 50,941 and $ 39,223 as of March 31, 2026 and December 31, 2025, and Series C Convertible Preferred Stock mezzanine liability was $ 68,400 as of March 31, 2026 and December 31, 2025, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise prices ranging from $0.0004 to $0.0014, the closing stock price of the Company's common stock on the date of valuation ranging from $0.0006 to $0.0014, an expected dividend yield of 0%, expected volatility ranging from 173.26% to 202.70%, risk-free interest rates ranging from 3.68% to 5.09%, and an expected term of 1 year. Series D Convertible Preferred Stock On March 17, 2025, the Board of Directors of the Company had authorized issuance of up to 210 shares of preferred stock, $0.001 par value per share, designated as Series D Convertible Preferred Stock (Note 8). Each share of Preferred Stock shall have a par value of $0.001 per share and a stated value of $ 1,200 , subject to the increase set forth in the Certificate of Designation. Dividends: Each share of Series D Convertible Preferred Stock shall be entitled to receive, and the Company shall pay, cumulative dividends of 12% per annum, payable quarterly, beginning on the Original Issuance Date and ending on the date that such share of Series D Convertible Preferred Share has been converted or redeemed (the “Dividend End Date”). Dividends may be paid in cash or in shares of Series D Convertible Preferred Stock. From and after the issuance date, in addition to the payment of dividends pursuant to Section 3 (a), each Holder shall be entitled to receive, and the Company shall pay, dividends on shares of Series D Convertible Preferred Stock equal to (on an as-if-converted-to-Common-Stock basis) and in the same form as dividends actually paid on shares of the common stock when, as and if such dividends are paid on shares of the common stock. The Company shall pay no dividends on shares of the common stock unless it simultaneously complies with the previous sentence. 22 Voting Rights : The Holder shall be entitled to vote on an as-converted basis (subject to the Beneficial Ownership Limitation), together with the holders of Common Stock, with respect to any question upon which the holders of Common Stock have the right to vote, except as may be otherwise provided by applicable law. Except as otherwise expressly provided herein or as required by law, the Holders of Series D Preferred Stock and the holders of Common Stock shall vote together and not as separate classes. Liquidation : Upon any liquidation, dissolution or winding up of the Company, whether voluntary or involuntary (a “Liquidation”), the Holders shall be paid, in preference and prior to any payment made to the holders of the Junior Securities and any other stock ranking in liquidation junior to the Series D Preferred Stock, an amount per share equal to the Stated Value (such amount is referred to herein as the “Liquidation Preference”). If upon a Liquidation Event, the assets to be distributed among the Holders shall be insufficient to permit payment in full to the Holders of the Liquidation Preference, then the entire assets of the Company shall be distributed ratably among such holders in proportion to the full respective Liquidation Preference to which they are entitled. Conversion : The Holder shall have the right, at any time to convert such shares into Common Stock into that number of shares of common stock (subject to the Beneficial Ownership Limitation (as defined below)) determined by dividing the Stated Value of such share of Series D Preferred Stock by the Optional Conversion Rate (as defined below) (each, and “Optional Conversion”) at a conversion rate of the volume-weighted average price (“VWAP”) for the Company’s common stock for the ten (10) Trading Days immediately preceding the date of such conversion (the “Optional Conversion Rate”). “Trading Days” shall mean a day on which the means the principal markets or exchange on which the common stock is listed or quoted for trading on the date in question is open for business. “Beneficial Ownership Limitation” shall mean 4.99% of the number of shares of the common stock outstanding immediately after giving effect to the issuance of shares of common stock issuable upon conversion of Series D Preferred Stock held by the applicable Holder. No fractional shares of Common Stock shall be issued upon conversion of shares of Series D Preferred Stock. If more than one share of Series D Preferred Stock shall be surrendered, or deemed surrendered, pursuant to subsection (c) above, for conversion at any one time by the same Holder, the number of full shares of Common Stock issuable upon conversion thereof shall be computed on the basis of the aggregate number of shares of such Series D Preferred Stock so surrendered. Any fractional share which would otherwise be issuable upon conversion of any shares of Series D Preferred Stock (after aggregating all shares of Series D Preferred Stock held by each holder) shall be rounded to the nearest whole number (with one-half being rounded upward). The Company shall reserve, free from preemptive rights, out of its authorized but unissued shares of Common Stock solely for the purpose of effecting the conversion of the shares of Series D Preferred Stock sufficient shares to provide for the conversion of all outstanding shares of Series D Preferred Stock. All shares of Common Stock which may be issued in connection with the conversion provisions set forth herein will, upon issuance by the Company, be validly issued, fully paid and non-assessable, with no personal liability attached to ownership thereof, and free from all taxes, liens or charges with respect thereto. All shares of Series D Preferred Stock which have been converted shall no longer be deemed to be outstanding and all rights with respect to such shares including the rights to receive dividends and to vote, shall immediately cease and terminate on the Optional Conversion Date, except only the right of the Holder thereof to receive shares of Common Stock in exchange thereof. The Series D Convertible Preferred Stock is classified as temporary equity, as it is convertible upon issuance at an amount equal to the lowest traded price for the Company’s common stock for the fifteen trading days immediately preceding the date of conversion. Based on the requirements of ASC 815, Derivatives and Hedging , the conversion feature represents an embedded derivative that is required to be bifurcated and accounted for as a separate derivative liability. The derivative liability is originally recorded at its estimated fair value and is required to be revalued at each conversion event and reporting period. Changes in the derivative liability fair value are reported in operating results for each reporting period. March 21, 2025 On March 21, 2025, pursuant to the terms of the SPA, GHS purchased 60 shares of Series D Convertible Preferred Stock for gross consideration of $ 60,000 . The Company paid $ 9,200 in selling commissions and legal fees to complete this financing. 23 On March 21, 2025 (the date of receipt of cash proceeds of $50,800), the Company valued the fair value of the derivative and recorded an initial derivative liability of $ 65,024 , $ 14,224 as day one loss on the derivative, $ 12,000 as interest expense, and $ 72,000 as Series D Convertible Preferred Stock mezzanine liability, and $ 50,800 as a loss recorded on issuance to interest expense. The expected term of the derivative in calculating the fair value of derivative liability is one year. The Company recalculated the value of the derivative liability associated with the convertible note and recorded a loss of $ 7,600 and a gain of $ 191 in connection with the change in fair market value of the derivative liability for the three months ended March 31, 2026 and 2025, respectively. In addition, the Company recorded $ 4,916 and $ 237 as preferred stock dividend expense for the three months ended March 31, 2026 and 2025, respectively. Preferred stock dividend payable to GHS on this derivative totaled $ 19,290 and $ 14,374 as of March 31, 2026 and December 31, 2025, respectively. The preferred stock dividend payable at March 31, 2026 included $12,544 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. GHS waived the cumulative penalty of $25,326 for non-payment of dividend as of March 31, 2026. Derivative liability payable for this transaction totaled $ 85,570 and $ 77,970 as of March 31, 2026 and December 31, 2025, and Series D Convertible Preferred Stock mezzanine liability was $ 72,000 as of March 31, 2026 and December 31, 2025, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise price ranging from $0.0004 to $0.0008, the closing stock price of the Company’s common stock on the date of valuation ranges from $0.0006 to $0.001, an expected dividend yield of 0%, expected volatility ranging from 173.26% to 199.73%, risk-free interest rates ranging from 3.68% to 4.04%, and an expected term of 1 year. April 10, 2025 On April 10, 2025, pursuant to the terms of the SPA, GHS purchased 45 shares of Series D Convertible Preferred Stock for gross consideration of $ 45,000 . The Company paid $ 900 in selling commissions and legal fees to complete this financing. On April 10, 2025 (the date of receipt of cash proceeds of $44,100), the Company valued the fair value of the derivative and recorded an initial derivative liability of $ 57,220 , $ 12,220 as day one loss on the derivative, $ 9,000 as interest expense, and $ 54,000 as Series D Convertible Preferred Stock mezzanine liability, and $ 45,000 as a loss recorded on issuance to interest expense. The expected term of the derivative in calculating the fair value of derivative liability is one year. The Company recalculated the value of derivative liability associated with the convertible note in connection with the change in fair market value of the derivative liability and recorded a loss of $ 5,700 for the three months ended March 31, 2026. In addition, the Company recorded preferred stock dividend expense of $ 2,632 for the three months ended March 31, 2026. Preferred stock dividend payable to GHS on this derivative totaled $ 7,825 and $ 5,193 as of March 31, 2026 and December 31, 2025, respectively. The preferred stock dividend payable at March 31, 2026 included $3,120 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. Derivative liability payable for this transaction totaled $ 64,177 and $ 58,477 as of March 31, 2026 and December 31, 2025, and Series D Convertible Preferred Stock mezzanine liability was $ 54,000 as of March 31, 2026 and December 31, 2025, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise price ranging from $0.0004 to $0.0007, the closing stock price of the Company’s common stock on the date of valuation ranges from $0.0006 to $0.0010, an expected dividend yield of 0%, expected volatility ranging from 173.26% to 199.89%, risk-free interest rates ranging from 3.68% to 3.97%, and an expected term of 1 year. May 14, 2025 - 1 On May 14, 2025, pursuant to the terms of the SPA, GHS purchased 11 shares of Series D Convertible Preferred Stock for gross consideration of $ 11,000 . The Company paid $ 220 in selling commissions and legal fees to complete this financing. 24 On May 10, 2025 (the date of receipt of cash proceeds of $10,780), the Company valued the fair value of the derivative and recorded an initial derivative liability of $ 13,815 , $ 2,815 as day one loss on the derivative, $ 2,200 as interest expense, $ 13,815 as Series D Convertible Preferred Stock mezzanine liability, and $ 11,000 as a loss recorded on issuance to interest expense. The expected term of the derivative in calculating the fair value of derivative liability is one year. The Company recalculated the value of derivative liability associated with the convertible note in connection with the change in fair market value of the derivative liability and recorded a loss of $ 1,393 for the three months ended March 31, 2026. In addition, the Company recorded preferred stock dividend expense of $ 644 for the three months ended March 31, 2026. Preferred stock dividend payable to GHS on this derivative totaled $ 1,755 and $ 1,111 as of March 31, 2026 and December 31, 2025, respectively. The preferred stock dividend payable at March 31, 2026 included $753 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. Derivative liability payable for this transaction totaled $ 15,688 and $ 14,294 as of March 31, 2026 and December 31, 2025, and Series D Convertible Preferred Stock mezzanine liability was $ 13,200 as of March 31, 2026 and December 31, 2025, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise price ranging from $0.0004 to $0.0007, the closing stock price of the Company’s common stock on the date of valuation ranges from $0.0006 to $0.0010, an expected dividend yield of 0%, expected volatility ranging from 191.75% to 199.89%, risk-free interest rates ranging from 3.68% to 4.14%, and an expected term of 1 year. May 14, 2025 - 2 On May 14, 2025, pursuant to the terms of the SPA, GHS purchased 25 shares of Series D Convertible Preferred Stock for gross consideration of $ 25,000 . The Company paid $ 500 in selling commissions and legal fees to complete this financing. On May 10, 2025 (the date of receipt of cash proceeds of $24,500), the Company valued the fair value of the derivative and recorded an initial derivative liability of $ 31,399 , $ 6,399 as day one loss on the derivative, $ 5,000 as interest expense, $ 13,815 as Series D Convertible Preferred Stock mezzanine liability, and $ 11,000 as a loss recorded on issuance to interest expense. The expected term of the derivative in calculating the fair value of derivative liability is one year. The Company recalculated the value of derivative liability associated with the convertible note in connection with the change in fair market value of the derivative liability and recorded a loss of $ 3,167 for the three months ended March 31, 2026. In addition, the Company recorded preferred stock dividend expense of $ 1,463 for the three months ended March 31, 2026. Preferred stock dividend payable to GHS on this derivative totaled $ 3,989 and $ 2,526 as of March 31, 2026 and December 31, 2025, respectively. The preferred stock dividend payable at March 31, 2026 included $1,711 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. Derivative liability payable for this transaction totaled $ 35,654 and $ 32,487 as of March 31, 2026 and December 31, 2025, and Series D Convertible Preferred Stock mezzanine liability was $ 30,000 as of March 31, 2026 and December 31, 2025, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise price ranging from $0.0004 to $0.0007, the closing stock price of the Company’s common stock on the date of valuation ranges from $0.0006 to $0.0010, an expected dividend yield of 0%, expected volatility ranging from 191.75% to 199.89%, risk-free interest rates ranging from 3.68% to 4.14%, and an expected term of 1 year. October 30, 2025 On October 30, 2025, pursuant to the terms of the SPA, GHS purchased 35 shares of Series D Convertible Preferred Stock for gross consideration of $ 35,000 . The Company paid $ 700 in selling commissions and legal fees to complete this financing. 25 On October 30, 2025 (the date of receipt of cash proceeds of $34,300), the Company valued the fair value of the derivative and recorded an initial derivative liability of $ 28,724 , $ 6,276 as day one loss on the derivative, $ 7,000 as interest expense, $ 7,000 as Series D Convertible Preferred Stock mezzanine liability, and $ 35,000 a loss recorded on issuance as interest expense. The expected term of the derivative in calculating the fair value of derivative liability is one year. The Company recalculated the value of derivative liability associated with the convertible note in connection with the change in fair market value of the derivative liability and recorded a loss of $ 4,433 for the three months ended March 31, 2026. In addition, the Company recorded preferred stock dividend expense of $ 1,927 for the three months ended March 31, 2026. Preferred stock dividend payable to GHS on this derivative totaled $ 3,026 and $ 1,099 as of March 31, 2026 and December 31, 2025, respectively. The preferred stock dividend payable at March 31, 2026 included $2,170 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. Derivative liability payable for this transaction totaled $ 49,916 and $ 45,482 as of March 31, 2026 and December 31, 2025, and Series D Convertible Preferred Stock mezzanine liability was $ 42,000 as of March 31, 2026 and December 31, 2025, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise price ranging from $0.00048 to $0.0005, the closing stock price of the Company’s common stock on the date of valuation ranges from $0.0005 to $0.0008, an expected dividend yield of 0%, expected volatility ranging from 173.26% to 198.95%, risk-free interest rates ranging from 3.48% to 3.70%, and an expected term of 1 year. December 2, 2025 On December 2, 2025, pursuant to the terms of the SPA, GHS purchased 34 shares of Series D Convertible Preferred Stock for gross consideration of $ 34,000 . The Company paid $680 in sales commissions and legal fees to complete this financing. On December 2, 2025 (the date of receipt of cash proceeds of $33,320), the Company valued the fair value of the derivative and recorded an initial derivative liability of $ 36,821 , $ 2,821 as day one loss on the derivative, $ 6,800 as interest expense, $ 6,800 as Series D Convertible Preferred Stock mezzanine liability, and $ 34,000 as a loss recorded on issuance as interest expense. The expected term of the derivative in calculating the fair value of derivative liability is one year. The Company recalculated the value of derivative liability associated with the convertible note in connection with the change in fair market value of the derivative liability and recorded a loss of $ 4,307 for the three months ended March 31, 2026. In addition, the Company recorded preferred stock dividend expense of $ 1,836 for the three months ended March 31, 2026. Preferred stock dividend payable to GHS on this derivative totaled $ 2,230 and $ 394 as of March 31, 2026 and December 31, 2025, respectively. The preferred stock dividend payable at March 31, 2026 included $1,841 of cumulative dividend payable at a default rate of 18% per annum pursuant to the terms of the agreement. Derivative liability payable for this transaction totaled $ 48,490 and $ 44,183 as of March 31, 2026 and December 31, 2025, and Series D Convertible Preferred Stock mezzanine liability was $ 40,800 as of March 31, 2026 and December 31, 2025, respectively. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise price ranging from $0.00048 to $0.0006, the closing stock price of the Company’s common stock on the date of valuation ranges from $0.0007 to $0.0008, an expected dividend yield of 0%, expected volatility ranging from 173.26% to 198.95%, risk-free interest rates ranging from 3.48% to 3.68%, and an expected term of 1 year. March 12, 2026 On March 12, 2026, pursuant to the terms of the SPA, GHS purchased 43 shares of Series D Convertible Preferred Stock for gross consideration of $ 43,000 . The Company paid $ 2,860 in sales commissions and legal fees to complete this financing. On March 12, 2026 (the date of receipt of cash proceeds of $40,140), the Company valued the fair value of the derivative and recorded an initial derivative liability of $ 57,006 , $ 16,866 as day one loss on the derivative, $ 8,600 as interest expense, $ 8,600 as Series D Convertible Preferred Stock mezzanine liability, and $ 40,140 as a loss recorded on issuance as interest expense. The expected term of the derivative in calculating the fair value of derivative liability is one year. 26 The Company recalculated the value of derivative liability associated with the convertible note in connection with the change in fair market value of the derivative liability and recorded a loss of $ 4,319 for the three months ended March 31, 2026. In addition, the Company recorded preferred stock dividend expense of $ 357 for the three months ended March 31, 2026. Preferred stock dividend payable to GHS on this derivative totaled $ 357 as of March 31, 2026. Derivative liability payable for this transaction totaled $ 61,325 as of March 31, 2026, and Series D Convertible Preferred Stock mezzanine liability was $ 51,600 as of March 31, 2026. The Company valued the conversion feature using the Black-Scholes option pricing model with the following assumptions: conversion exercise price ranging from $0.00048 to $0.0006, the closing stock price of the Company’s common stock on the date of valuation ranges from $0.0008 to $0.0010, an expected dividend yield of 0%, expected volatility ranging from 173.26% to 175.68%, risk-free interest rates ranging from 3.66% to 3.68%, and an expected term of 1 year. Series E Preferred Stock On October 30, 2025, the Board of Directors of the Company had authorized issuance of up to 3,000 shares of preferred stock, $ 0.001 par value per share, designated as Series E Convertible Preferred Stock. Each share of Preferred Stock shall have a par value of $0.001 per share and a stated value of $ 1,200 , subject to the increase set forth in the Certificate of Designation. Dividends : Each share of Preferred Stock shall be entitled to receive, and the Corporation shall pay, cumulative dividends of 10% per annum, payable quarterly, beginning on the Original Issue Date and ending on the date that such share of Preferred Share has been converted or redeemed. Dividends may be paid in cash or in shares of Preferred Stock, at the Corporation’s discretion. From and after the initial Closing Date, in addition to the payment of dividends, each Holder shall be entitled to receive, and the Corporation shall pay, dividends on shares of Preferred Stock equal to (on an as-if-converted-to-Common-Stock basis) and in the same form as dividends actually paid on shares of the Common Stock when, as and if such dividends are paid on shares of the Common Stock. The Corporation shall pay no dividends on shares of the Common Stock unless it simultaneously complies with the previous sentence. Any dividends that are not paid a Dividend Payment Date shall continue to accrue and shall entail a late fee (“ Late Fees ”), which must be paid in cash, at the rate of 12% per annum or the lesser rate permitted by applicable law which shall accrue and compound daily from the Dividend Payment Date through and including the date of actual payment in full. Voting Rights . The Preferred Stock will vote together with the common stock on an as-converted basis subject to the Beneficial Ownership Limitations. However, as long as any shares of Preferred Stock are outstanding, the Corporation shall not, without the affirmative vote of the Holders of a majority of the then outstanding shares of the Preferred Stock directly and/or indirectly (a) alter or change adversely the powers, preferences or rights given to the Preferred Stock or alter or amend this Certificate of Designation, (b) authorize or create any class of stock ranking as to redemption or distribution of assets upon a Liquidation (as defined in Section 5) senior to, or otherwise pari passu with, the Preferred Stock or, authorize or create any class of stock ranking as to dividends senior to, or otherwise pari passu with, the Preferred Stock, (c) amend its Articles of Incorporation or other charter documents in any manner that adversely affects any rights of the Holders, (d) increase the number of authorized shares of Preferred Stock, or (e) enter into any agreement with respect to any of the foregoing. Liquidation: Upon any liquidation, dissolution or winding-up of the Corporation, whether voluntary or involuntary (a “ Liquidation ”), the Holders shall be entitled to receive out of the assets, whether capital or surplus, of the Corporation an amount equal to the Stated Value, plus any accrued and unpaid dividends thereon and any other fees or liquidated damages then due and owing thereon under this Certificate of Designation, for each share of Preferred Stock before any distribution or payment shall be made to the holders of any Junior Securities, and if the assets of the Corporation shall be insufficient to pay in full such amounts, then the entire assets to be distributed to the Holders shall be ratably distributed among the Holders in accordance with the respective amounts that would be payable on such shares if all amounts payable thereon were paid in full. A Fundamental Transaction or Change of Control Transaction shall not be deemed a Liquidation. The Corporation shall mail written notice of any such Liquidation, not less than forty-five (45) days prior to the payment date stated therein, to each Holder. Conversion: Each share of Preferred Stock shall be convertible, at any time and from time to time from and after the Original Issue Date at the option of the Holder thereof, into that number of shares of Common Stock (subject to certain limitations) determined by dividing the Stated Value of such share of Preferred Stock by Conversion Price. Holders shall effect conversions by providing the Corporation with the form of conversion notice. Each Notice of Conversion shall specify the number of shares of Preferred Stock to be converted, the number of shares of Preferred Stock owned prior to the conversion at issue, the number of shares of Preferred Stock owned subsequent to the conversion at issue and the date on which such conversion is to be effected, which date may not be prior to the date the applicable Holder delivers by facsimile or email such Notice of Conversion to the Corporation (such date, the “ Conversion Date ”). If no Conversion Date is specified in a Notice of Conversion, the Conversion Date shall be the date that such Notice of Conversion to the Corporation is deemed delivered hereunder. The calculations and entries set forth in the Notice of Conversion shall control in the absence of manifest or mathematical error. To effect conversions of shares of Preferred Stock, a Holder shall not be required to surrender the certificate(s) representing the shares of Preferred Stock to the Corporation unless all of the shares of Preferred Stock represented thereby are so converted, in which case such Holder shall deliver the certificate representing such shares of Preferred Stock promptly following the Conversion Date at issue. Shares of Preferred Stock converted into Common Stock or redeemed in accordance with the terms hereof shall be canceled and shall not be reissued. 27 Conversion price: The conversion price for the Preferred Stock shall be a fixed price equal to $0.0005. All such foregoing determinations will be appropriately adjusted for any stock dividend, stock split, stock combination, reclassification or similar transaction that proportionately decreases or increases the Common Stock during such measuring period. Nothing herein shall limit a Holder’s right to pursue actual damages including, but not limited to, as a result of a Triggering Event pursuant to Section 10 hereof and the Holder shall have the right to pursue all remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief. The exercise of such rights shall not prohibit the Holder from seeking to enforce damages pursuant to any other Section hereof or under applicable law. Corporation Redemption: The Corporation shall have the right to redeem, all (but not less than all), shares of the Preferred Stock issued and outstanding at any time after the Original Issue Date, upon three (3) business days’ notice, at a redemption price per Preferred Stock then issued and outstanding (the “ Corporation Redemption Price ”), equal to the product of (i) the Premium Rate (means 1.10) multiplied by (ii) the sum of (x) the Stated Value, (y) all accrued but unpaid dividends, and (z) all other amount due to the Holder pursuant to this Certificate of Designation and/or any Transaction Document including, but not limited to Late Fees, liquidated damages and the legal fees and expenses of the Holder’s counsel relating to this Certification of Designation, any other Transaction Document and/or the transactions contemplated thereunder and/or hereunder. Notwithstanding the delivery of a Corporation Redemption Notice, a Holder may convert some or all of its shares of Preferred Stock until the date it receives in full Corporation Redemption Price, provided , however , that notwithstanding anything to the contrary provided herein or elsewhere (i) in the event a Holder would be precluded from converting any shares of Preferred Stock, due to the limitation contained in Section 5, the Corporation Redemption Payment Date, for such Holder only, shall automatically be extended by one hundred twenty (120) days (or such shorter period as so provided to the Corporation by the Holder at any time and (ii) if a Mandatory Conversion has occurred prior to the Corporation Redemption Payment Date and for whatever reason including, but not limited to, the Beneficial Ownership Limitation, a Holder still owns Preferred Stock, any such Holder may elect to extend the Corporation Redemption Payment Date as to any or all of such Holder’s Preferred Stock for up to one hundred twenty (120) days following the Corporation Redemption Payment Date to allow such Holder to convert its remaining Preferred Stock into Conversion Shares. On October 30, 2025, the Company entered into a Debt Exchange Agreement (the “Emmons DEA”) with Clifford L. Emmons, it’s Chief Executive Officer and Director. Pursuant to the Emmons DEA, Mr. Emmons exchanged $ 387,242 of accrued compensation and unpaid fees owed to him by the Company under various agreements, for 269 shares of the Company’s Series E Convertible Preferred Stock (the “Series E Preferred Stock”). In addition to the issuance of the Company’s Series E Preferred Stock, Mr. Emmons agreed to cancel 7,800 shares of Series A Preferred Stock owned by him. The closing of the Emmons DEA occurred on November 5, 2025. The Company recorded dividend expense of $ 8,237 for the three months ended March 31, 2026, The Company recorded $ 13,796 and $ 5,599 as dividend payable to Mr. Emmons as of March 31, 2026 and December 31, 2025, respectively. On October 30, 2025, the Company entered into a Debt Exchange Agreement (the “Mitta DEA”) with Vidhyadhar Mitta, it’s former Director. Pursuant to the Mitta DEA, Mr. Mitta exchanged $ 216,156 of principal and accrued and unpaid interest owed to him by the Company under the 12% Secured Convertible Promissory Note issued to Mr. Mitta on August 2, 2019 for 180 shares of Series E Preferred Stock. In addition to the issuance of the Series E Preferred Stock, Mr. Mitta agreed to cancel 12,000 shares of Series A Preferred Stock owned by him. The closing of the Mitta DEA occurred on November 5, 2025. The Company recorded dividend expense of $ 5,512 for the three months ended March 31, 2026. The Company recorded $ 9,233 and $ 5,559 as dividend payable to Mr. Mitta as of March 31, 2026 and December 31, 2025, respectively. On October 30, 2025, the Company entered into a Debt Exchange Agreement (the “McNemar DEA”) with Karen McNemar, it’s former Chief Financial Officer. Pursuant to the McNemar DEA, Ms. McNemar exchanged $ 323,269 of accrued and unpaid fees owed to her by the Company under various agreements for 269 shares of Series E Preferred Stock. In addition to the issuance of the Series E Preferred Stock, Ms. McNemar agreed to cancel 6,045 shares of Series A Preferred Stock owned by her. The closing of the McNemar DEA occurred on November 5, 2025. The Company recorded dividend expense of $ 8,237 for the three months ended March 31, 2026. The Company recorded $ 13,796 and $ 5,559 as dividend payable to Ms. McNemar as of March 31, 2026 and December 31, 2025, respectively. On October 30, 2025, the Company entered into a Debt Exchange Agreement (the “Senior Secured DEA”) with Sergey Gogin and Yvsgramorah, LLC, an entity controlled by Mr. Gogin (the “Senior Secured Holders”). Pursuant to the Senior Secured DEA, the Senior Secured Holders exchanged an aggregate of $ 522,195 of principal and accrued and unpaid interest owed to the Senior Secured Holders by the Company under the Senior Secured Convertible Note issued to Mr. Gogin on January 22, 2018 (the “Gogin Note”) and the Senior Secured Convertible Note issued to Yvsgramorah, LLC on March 6, 2019 (the “YVS Note,” together, with the Gogin Note, the “Senior Secured Notes”) for an aggregate of 489 shares (the “Senior Secured Shares”) of Series E Preferred Stock. The closing of the Senior Secured DEA occurred on November 5, 2025. The Company recorded dividend expense of $ 14,973 for the three months ended March 31, 2026. The Company recorded $ 25,079 and $ 10,106 as dividend payable to Mr. Gogin as of March 31, 2026 and December 31, 2025, respectively. 28 The following table represents the change in the fair value of the derivative liabilities for the three months ended March 31, 2026 and 2025, respectively. Schedule of change in the fair value of the derivative liabilities Level 1 Level 2 Level 3 Balance at December 31, 2024 $ – $ – $ 758,787 Additions to derivative liability – – 64,985 Gain due to change in the fair value of derivative liability – – ( 15,724 ) Balance at March 31, 2025 $ – $ – $ 808,048 Balance at December 31, 2025 $ – $ – $ 951,532 Additions to derivative liability – – 57,006 Loss due to change in the fair value of derivative liability – – 97,220 Balance at March 31, 2026 $ – $ – $ 1,105,758 As a result of issuance of derivative instruments, the Company recorded a derivative liability of $ 1,105,758 and $ 951,532 as of March 31, 2026 and December 31, 2025, Series B Convertible Preferred Stock liability of $ 699,600 as of March 31, 2026 and December 31, 2025, Series C Convertible Preferred Stock liability of $ 68,400 as of March 31, 2026 and December 31, 2025, and Series D Convertible Preferred Stock liability of $ 303,600 and $ 252,000 as of March 31, 2026 and December 31, 2025, respectively. NOTE 8 – SUBSEQUENT EVENTS Management has evaluated all subsequent events through the date of filing. On April 10, 2026, the Board of Directors adopted a resolution to terminate the company’s three equity compensation plans: the 2017 Stock Incentive Plan (the “2017 Plan”), the 2019 Stock Incentive Plan (the “2019 Plan”), and the 2022 Stock Incentive Plan (the “2022 Plan”). Each of the Plans was terminated effective December 31, 2025. On April 16, 2026, the Board of Directors adopted a resolution to approve and authorize an amendment to the Original Certificate of Designation for Series D to increase the total number of authorized shares of Series D Preferred Stock from 210 shares to 500 shares. On April 21, 2026, GHS Investments entered into a financing arrangement and purchased 45 shares of Series D Convertible Preferred Stock, $0.001 par value, $1,200 stated value, for a cash consideration of $43,100, The Company paid sales commissions of $900 and $1,000 in legal fees to complete this sale transaction. On May 6, 2026, the Company entered into an extension to the July 29, 2020 Convertible Promissory Note G issued to GHS Investments in the original principal amount of $75,000.. The maturity date of the Note G was extended from April 29, 2026 to October 31, 2026. In addition, all prior Events of Default (as defined in the Note) were waived by GHS (Note 4). On June 12, 2026, GHS Investments entered into a financing arrangement and purchased 37 shares of Series D Convertible Preferred Stock, $0.001 par value, $1,200 stated value, for a cash consideration of $36,280. The Company paid sales commissions of $720. On July 9, 2026, GHS Investments entered into a financing arrangement and purchased 27 shares of Series D Convertible Preferred Stock, $0.001 par value, $1,200 stated value, for a cash consideration of $26,460. The Company paid sales commissions of $540. 29 Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations This Management’s Discussion and Analysis of Financial Condition and Results of Operations contain certain forward-looking statements. Historical results may not indicate future performance. Our forward-looking statements reflect our current views about future events; are based on assumptions and are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those contemplated by these statements. We undertake no obligation to publicly update or revise any forward-looking statements, including any changes that might result from any facts, events, or circumstances after the date hereof that may bear upon forward-looking statements. Furthermore, we cannot guarantee future results, events, levels of activity, performance, or achievements Basis of Presentation The financial information presented below and the following Management Discussion and Analysis of the Consolidated Financial Condition, Results of Operations, Stockholders’ Equity and Cash Flow for the quarterly periods ended March 31, 2026 and 2025 gives effect to our acquisition of OXYS Corporation (“ OXYS ”) on July 28, 2017. In accordance with the accounting reporting requirements for the recapitalization related to the “reverse merger” of OXYS, the financial statements for OXYS have been adjusted to reflect the change in the shares outstanding and the par value of the common stock of OXYS. Additionally, all intercompany transactions between the Company and OXYS have been eliminated. Forward-Looking Statements Statements in this management’s discussion and analysis of financial condition and results of operations contain certain forward-looking statements. To the extent that such statements are not recitations of historical fact, such statements constitute forward looking statements which, by definition, involve risks and uncertainties. Where in any forward-looking statements, if we express an expectation or belief as to future results or events, such expectation or belief is expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the statement of expectation or belief will result or be achieved or accomplished. Factors that may cause differences between actual results and those contemplated by forward-looking statements are not limited to the following: · the impact of conflicts between the Russian Federation and Ukraine and Israel in on our operations; · geo-political events, such as the crisis in Ukraine and Israel, government responses to such events and the related impact on the economy both nationally and internationally; · general market and economic conditions; · our ability to maintain and grow our business with our current customers; · our ability to meet the volume and service requirements of our customers; · industry consolidation, including acquisitions by us or our competitors; · capacity utilization and the efficiency of manufacturing operations; 30 · success in developing new products; · timing of our new product introductions; · new product introductions by competitors; · the ability of competitors to more fully leverage low-cost geographies for manufacturing or distribution; · product pricing, including the impact of currency exchange rates; · effectiveness of sales and marketing resources and strategies; · adequate manufacturing capacity and supply of components and materials; · strategic relationships with our suppliers; · product quality and performance; · protection of our products and brand by effective use of intellectual property laws; · the financial strength of our competitors; · the outcome of any future litigation or commercial dispute; · barriers to entry imposed by competitors with significant market power in new markets; and · government actions throughout the world. You should not rely on forward-looking statements in this document. This management’s discussion contains forward looking statements that involve risks and uncertainties. We use words such as “anticipates,” “believes,” “plans,” “expects,” “future,” “intends,” and similar expressions to identify these forward-looking statements. Prospective investors should not place undue reliance on these statements, which apply only as of the date of this document. Our actual results could differ materially from those anticipated in these forward-looking statements. Critical Accounting Policies The following discussions are based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. These financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires management to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures of contingencies. We continually evaluate the accounting policies and estimates used to prepare the financial statements. We base our estimates on historical experiences and assumptions believed to be reasonable under current facts and circumstances. Actual amounts and results could differ from these estimates made by management. 31 We regularly review the carrying value and estimated lives of its long-lived assets to determine whether indicators of impairment may exist that warrant adjustments to the carrying value or estimated useful lives. The determinants used for this evaluation include management’s estimate of the asset’s ability to generate positive income from operations and positive cash flow in future periods as well as the strategic significance of the assets to the Company’s business objectives. Definite-lived intangible assets are amortized on a straight-line basis over the estimated periods benefited and are reviewed when appropriate for possible impairment. When we issue convertible debt or convertible preferred stock, we first evaluate the balance sheet classification of the convertible instrument in its entirety to determine whether the instrument should be classified as a liability under ASC 480, Distinguishing Liabilities from Equity , and second whether the conversion feature should be accounted for separately from the host instrument. A conversion feature of a convertible debt instrument or certain convertible preferred stock would be separated from the convertible instrument and classified as a derivative liability if the conversion feature, were it a standalone instrument, meets the definition of an “embedded derivative” in ASC 815, Derivatives and Hedging . Generally, characteristics that require derivative treatment include, among others, when the conversion feature is not indexed to the Company’s equity, as defined in ASC 815-40, or when it must be settled either in cash or by issuing stock that is readily convertible to cash. When a conversion feature meets the definition of an embedded derivative, it would be separated from the host instrument and classified as a derivative liability carried on the consolidated balance sheet at fair value, with any changes in its fair value recognized currently in the consolidated statements of operations. Historical Background We were incorporated in the State of New Jersey on October 1, 2003 under the name of Creative Beauty Supply of New Jersey Corporation and subsequently changed our name to Gotham Capital Holdings, Inc. on May 18, 2015. We commenced operations in the beauty supply industry as of January 1, 2004. On November 30, 2007, our Board of Directors approved a plan to dispose of our wholesale and retail beauty supply business. From January 1, 2009 until July 28, 2017, we had no operations and were a shell company. On March 16, 2017, our Board of Directors adopted resolutions, which were approved by shareholders holding a majority of our outstanding shares, to change our name to “IIOT-OXYS, Inc.”, to authorize a change of domicile from New Jersey to Nevada, to authorize a 2017 Stock Awards Plan, and to approve the Securities Exchange Agreement (the “ OXYS SEA ”) between the Company and OXYS Corporation (“ OXYS ”), a Nevada corporation incorporated on August 4, 2016. Under the terms of the OXYS SEA we acquired 100% of the issued voting shares of OXYS in exchange for 34,687,244 shares of our Common Stock. We also cancelled 1,500,000 outstanding shares of our Common Stock and changed our management to Mr. DiBiase who also served in the management of OXYS. Also, one of our principal shareholders entered into a consulting agreement with OXYS to provide consulting services during the transition. The OXYS SEA was effective on July 28, 2017, and our name was changed to “IIOT-OXYS, Inc.” at that time. Effective October 26, 2017, our domicile was changed from New Jersey to Nevada. On October 30, 2025, we had a change of control in management, and the Company and its debtholders mutually agreed to convert their convertible promissory notes due, and compensation due to officers in exchange for issuance of Series E Preferred Stock in full settlement of all balances due. At the present time, we have two wholly owned subsidiaries which are OXYS Corporation and HereLab, Inc. (an entity immaterial to our operations), through which our operations are conducted. General Overview IIOT-OXYS, Inc., a Nevada corporation (the “ Company ”), and OXYS, were originally established for the purposes of designing, building, testing, and selling Edge Computing systems for the Industrial Internet. Both companies were early-stage technology startups that are largely pre-revenue in their development phase. HereLab (an entity immaterial to our operations) is also an early-stage technology development company. 32 We develop hardware, software and algorithms that monitor, measure and predict conditions for energy, structural, agricultural and medical applications. We use domain-specific Artificial Intelligence to solve industrial and environmental challenges. Our engineered solutions focus on common sense approaches to machine learning, algorithm development and hardware and software products. We use off-the-shelf components, with reconfigurable hardware architecture that adapts to a wide range of customer needs and applications. We use open-source software tools, while still creating proprietary content for customers, thereby reducing software development time and cost. The software works with the hardware to collect data from the equipment or structure that is being monitored. We focus on developing insights. We develop algorithms that help our customers create insights from vast data streams. The data collected is analyzed and reports are created for the customer. From these insights, the customer can act to improve their process, product or structure. Results of Operations for the Three Months Ended March 31, 2026 Compared to the Three Months Ended March 31, 2025 (Unaudited) For the three months ended March 31, 2026, we did not record any revenues and related cost of sales. Our operating expenses totaled $63,589 which included professional fees of $56,224 for accounts, attorneys and consultants, and general and administrative expenses of $7,365. We recorded net other expenses of $162,573 consisting of a loss of $97,220 due to change in fair market value of derivative liability; loss on derivatives of $16,866; interest expense of $49,084 on promissory notes payable; and $597 of refund received upon department of treasury. We also recorded preferred stock dividend of $167,511 on convertible preferred stocks. As a result of the above, we recorded a net loss of $393,673 attributable to common stockholders for the three months ended March 31, 2026. For the three months ended March 31, 2025, we did not record any revenues and related cost of sales. Our operating expenses totaled $92,258 which included payroll costs of $50,000, amortization of intangible assets of $12,205, and general and administrative expenses of $30,053. We recorded net other expense of $64,953 consisting of gain of $15,764 due to change in fair market value of derivative liability; loss on derivatives of $14,224; interest expense of $75,375 primarily due to recording of $62,800 as interest expense on issuance of Series D Convertible Preferred Stock; and other income of $8,882 received as employee retention credit from the Internal Revenue Service in February 2025.We also recorded preferred stock dividend on convertible preferred stock of $23,102. As a result of the above, we recorded a net loss of $180,313 attributable to common stockholders for the three months ended March 31, 2025. During the current and prior period, we did not record an income tax benefit due to the uncertainty associated with the Company’s ability to utilize the deferred tax assets. No revenues were earned in Q1, 2026, as in prior year quarter ending March 31, 2025. We believe revenue growth for the rest of 2026 will be challenging given the difficulty in raising additional capital to fuel sales and marketing efforts. Potential future revenue growth depends on our ability to raise said capital and the following factors: · Our DOT Bridge Monitoring Contract ended in December 2023 but we believe our Structural Health Monitoring (“ SHM ”) vertical is the foundation of our future revenue stream. Discussions with our main contractor to the DOT revealed that the monitoring program in which we’ve participated in previous years has been suspended with no foreseeable plans to restart the program. Despite this setback, our main contractor has confirmed we can continue to monitor our two sites (at our cost), which will allow us to effectively market our system and services to local municipalities and other state DOTs. We continue to pursue DOT contacts in two other northeast states, but these may not convert to contracts for another year. Projects with local municipalities in our current northeast state also continue to be prospected and may convert to contracts sometime in 2026, as they are based on potential state grants and not dependent on state or municipal budget cycles. 33 · Our Smart Manufacturing vertical is another potential source of future revenue based on the strong use case developed from our CNC POC and SaaS contracts in previous years. Although the SaaS contract ended in May 2024, the tool cost savings exceeded our projections and our customer’s expectations. This previous customer will continue to endorse our capabilities and services, including promotional video material previously released and pending. We believe their endorsement and promotional videos are valuable collateral to prospect future Smart Manufacturing CNC business. Additional POCs for other discrete manufacturing processes, including metal stamping, plastic injection molding, plastic extrusion, and automated assembly and test are also potential avenues of future revenue streams. · We believe our strategic partnership continues to be our greatest asset. The strength of our Aingura IIoT, S.L. partnership provides supplemental expertise, equipment and software, which ensures our ability to bring value to our prospective customers. Their recent successes in expanding their minimally invasive monitoring and predictive algorithms into heavy industrial equipment applications bodes well for additional U.S. collaborations with us. Despite these positive factors, we continue to face significant headwinds and we have not been able to raise material funds for ongoing operations through our existing financing agreements due to market conditions. Our management continues to secure limited funding from our lead investor to pay for ongoing expenses and our leadership team is considering our options for both the short and long term. Given the current challenges in raising adequate funds, management is pursuing options including vetting suitable companies to merge with or acquire us. We believe we’ve created valuable assets from our business development in these industries, which are strong in both their size and growth. The global smart manufacturing (also known as Industry 4.0) was 233.3 billion in 2024 and will reach $479 billion by 2029 (CAGR 15.5%) 1 , and the worldwide SHM industry is $2.5 billion in 2024 and will reach $4.1 billion by 2029 (CAGR of 10.4%) 2 . Given the valuable real-world data we have collected, our Artificial Intelligence (“ AI ”) Machine Learning algorithms we have developed, strong use cases and marketing collateral developed from our data and algorithms, combined with our prudent operational execution, we believe our company’s assets have potential future revenue growth, that will be attractive to prospective partners interested in an acquisition or merger. On November 5 th , 2025, control of the Company was transferred to our lead investor GHS. Vidhydahar Mitta, our former independent board member, and Karen McNemar, our former interim CFO and COO, have resigned their positions. We thank them for their service to the Company. Cliff Emmons will continue in the role of CEO and, together with our new board, we are optimistic that under this new leadership the Company will have greater access to capital to secure additional assets for the Company, including potential synergistic mergers. We expect the net result will be increased shareholder value. Liquidity and Capital Resources for the Three Months Ended March 31, 2026 Compared to the Three Months Ended March 31, 2025 (Unaudited) At March 31, 2026, we reported a cash balance of $6,838 as a result of net decrease of cash balance of $19,504 from $26,342 at December 31, 2025. This decrease was primarily as a result of net cash used in operating activities of $59,624, offset by net cash provided by sale of Series D convertible preferred stock of $43,000, and cash payment of $2,880 in offering costs. ___________________ 1 https://www.marketsandmarkets.com/Market-Reports/smart-manufacturing-market-105448439.html 2 https://www.marketsandmarkets.com/Market-Reports/structural-health-monitoring-market-101431220.html 34 Operating Activities Net cash flows used in operating activities for the three months ended March 31, 2026 was $59,624, primarily attributed to the net loss of $226,162, common stock issued for services of $100, amortization of debt discount on Series B and D convertible preferred stock of $8,600, loss due to change in the fair value of derivative liability of $97,220, and net increase in operating assets and liabilities of $60,618. The Company recorded changes in operating assets and liabilities primarily attributable to decrease in accounts payable of $9,242, increase in accrued liabilities of $12,854, and an increase in derivative liabilities of $57,006. Net cash flows used in operating activities for the three months ended March 31, 2025 was $56,532, primarily attributed to the net loss of $157,211, stock compensation expense for services of $1,295, amortization of intangible assets of $12,205, gain due to change in fair value of derivative liability of $15,764 of Series C and Series D Convertible Preferred Stock, and net increase in operating assets and liabilities of $90,943. The Company recorded changes in operating assets and liabilities primarily attributable to an increase in prepaid expenses and other current assets of $15,000, decrease in accounts payable of $34,827, increase in accrued liabilities of $638,986, increase in derivative liabilities of $69,825, increase in shares payable to related parties of $360, and increase in salaries payable to related parties of $31,599. Investing Activities Net cash used in investing activities for the three months ended March 31, 2026 and 2025 was $0. Financing Activities Net cash provided by financing activities for the three months ended March 31, 2026, was $40,120, due to cash received from sale of Series D Convertible Preferred Stock of $43,000, and cash payments of offering costs of $2,880. Net cash provided by financing activities for the three months ended March 31, 2025, was $50,800, due to cash received from sale of Series D Convertible Preferred Stock of $60,000, net of cash payments of offering costs of $9,200. As a result of the above activities, the Company recorded a decrease in cash of $19,504 for the three months ended March 31, 2026, respectively. The accompanying condensed unaudited consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As shown in the accompanying financial statements, the Company has suffered continuing operating losses, has a working capital deficit of $2,653,885, net loss from operations for the three months ended March 31, 2026 of $226,162, net cash used in operating activities of $59,624, and has an accumulated deficit of $13,043,185 as of March 31, 2026. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. If the Company is unable to obtain adequate capital, it could be forced to cease operations. The accompanying condensed unaudited financial statements do not include any adjustments to reflect the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. Off-Balance Sheet Arrangements We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future material effect on our consolidated financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity capital expenditures or capital resources. 35 Item 3. Quantitative and Qualitative Disclosures About Market Risk As a smaller reporting company, the Company has elected not to provide the disclosure required by this item. Item 4. Controls and Procedures Disclosure Controls and Procedures The Company has established disclosure controls and procedures that are designed to ensure that information required to be disclosed in reports filed or submitted under the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission and, as such, is accumulated and communicated to the Company’s Chief Executive Officer, Clifford L. Emmons, who serves as our principal executive officer and principal financial and accounting officer, to allow timely decisions regarding required disclosure. Mr. Emmons evaluated the effectiveness of the Company’s disclosure controls and procedures, as defined in Rule 13a-15(e) of the Exchange Act, as of March 31, 2026. Based on his evaluation, Mr. Emmons concluded that the Company’s disclosure controls and procedures were not effective as of March 31, 2026. Changes in Internal Control Over Financial Reporting There has been no change in the Company’s internal control over financial reporting, as defined in Rules 13a-15(f) of the Exchange Act, during the Company’s quarter ended March 31, 2026, that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting. 36 PART II—OTHER INFORMATION Item 5. Other Information. During the quarter ended March 31, 2026, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K. Item 6. Exhibits. SEC Ref. No. Title of Document 10.1* Securities Purchase Agreement dated March 6, 2026 with GHS Investments, LLC 31.1* Rule 13a-14(a) Certification by Principal Executive Officer 31.2* Rule 13a-14(a) Certification by Principal Financial and Accounting Officer 32.1** Section 1350 Certification of Principal Executive Officer 101.INS* Inline XBRL Instance Document 101.SCH* Inline XBRL Taxonomy Extension Schema Document 101.CAL* Inline XBRL Taxonomy Extension Calculation Linkbase Document 101.DEF* Inline XBRL Taxonomy Extension Definition Linkbase Document 101.LAB* Inline XBRL Taxonomy Extension Label Linkbase Document 101.PRE* Inline XBRL Taxonomy Extension Presentation Linkbase Document 104* Cover Page Interactive Data File (formatted in iXBRL, and included in exhibit 101) *Filed with this Report. **Furnished with this Report. 37 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. IIOT-OXYS, Inc. Date: July 9, 2026 By /s/ Clifford L. Emmons Clifford L. Emmons, Chief Executive Officer (Principal Executive Officer and Principal Financial and Accounting Officer) 38